KEY OPINION LEADERS

Find out who has spoken at Galien Foundation
meetings and events

We are determined to ensure that Galien Foundation events are second-to-none in caliber. Our forums, meetings and digital events bring together the world’s thought leaders in one singular mission - to improve the human condition. Discover who has spoken at our events by searching below.

Image 81-1
Who are you looking for?
Image 81-1
NAME COMPANY TITLE EVENT TOPIC COUNTRY
2022 Juan Camilo Arjona Ferreira Myovant Sciences CMO Galien Week of Innovation Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2022 Javier Boix Novartis Global Head, Communications & Engagement, Novartis Pharmaceuticals Galien Webinars Series Golden Jubilee - Best Pharmaceutical Category
2020 Jeremy Abbate Scientific American Vice President & Publisher Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2018 Salim Abdool Karim Columbia University Professor Galien Forum Africa managing infectious diseases & pandemics
2018 Salim Abdool Karim Columbia University Professor for Global Health Galien Forum Africa Remarkable women engage for humanity
2018 Papa Abdoulaye Seck Senegal Minister of Agriculture Galien Forum Africa Addressing chronic malnutrition
2020 Amy Abernethy FDA Principal Deputy Commissioner Galien Webinars Series Digital health improving research & care
2021 Imodoye Abioro Healthbotics Chief Executive Officer Galien Forum Africa Leadership & innovation, meet the winners of the africa young innovators award for health
2018 Anna K. Abram FDA Deputy Commissioner for Policy, Planning, Legislation & Analysis. Galien Forum USA Keynote
2022 Michael D. Abramoff Digital Diagnostics Inc Digital Diagnostics Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Paul Adam Boehringer Head Cancer Immuno MOD Galien Week of Innovation Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence
2018 Isaac Adewole Nigeria Minister of Health Galien Forum Africa Which plan for non communicable diseases?
2021 Nanahemaa Adjoa Awindor Development Queenmother Afigya-Kwabre District – Ghana Professor Galien Forum Africa Women’s leadership in global health security
2021 Desmond Adler Glaukos Corporation General Manager & Vice President R&D, Corneal Health Galien Week of innovation What is med tech innovation doing for patients with specialized needs for treatment?
2018 Sultana Afdhal WISH, Qatar Chief Executive Officer Galien Forum Africa Plenary Panel - women in stem in africa
2014 Mohammad Afshar Ariana pharma CEO Galien Foum Monaco Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021 Shefali Agarwal Epizyme Chief Medical & Development Officer & trained medical oncologist Galien Week of innovation Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2018 Cinzia Akbaraly Akbaraly Foundation - Madagascar Founder & President Galien Forum Africa Plenary Panel - women in stem in africa
2022 Sarah Akerman Alkermes, Inc Executive Medical Director Galien Week of Innovation Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2018 Sarah Akerman Alkermes Senior Medical Director Galien Forum USA Novel approaches to combatting opioid addiction
2021 Bola Akinlade Regeneron Vice President, Clinical Sciences, Immunology & Inflammation Galien Week of innovation Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions?
2021 Chrispin Akuzwe Patient Monitoring System – Rwanda Smart Chair Galien Forum Africa Meeting of young innovators with investors
2021 David E. Albert AliveCor Inc. Founder & Chief Medical Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2016 Charles Albright Editas Journalist Galien Forum USA Molecular scissors: what can we expect from gene editing?
2022 Alexey Aleshin Natera, Inc. MD, MBA Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2022 Sally Allain Johnson & Johnson Innovation, LLC Head of Innovation Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2013 David Altshuler Massachusetts General Hospital & Broad Institute Professor Galien Forum USA Personalized medicine: effect on drug r&d & patient care
2021 Yele Aluko EY Americas Business Consulting Health Sector Chief Medical Officer Jerusalem Ethics Forum Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2021 Pape  Amadou Sarr Delegation à l’Entreprenariat Rapid– Senegal Director General Galien Forum Africa Meeting of young innovators with investors
2021 Samuel  Amo Tobbin TOBINCO Group of Companies – Ghana Executive Director  Galien Forum Africa Meeting of young innovators with investors
2021 Samuel Amo Tobbin TOBINCO Group of Companies – Ghana Executive Director Galien Forum Africa Closing ceremony
2022 Aseem Anand Lantheus VP Digi Imaging Biomarkers Lantheus Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2022 David E. Anderson VBI Vaccines Inc. Chief Scientific Officer Galien Week of Innovation Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2022 Emily Anderson Boston Scientific Corp. Director, Global Corporate Communications Galien Webinars Series Golden Jubilee - Best MedTech Category
2014 David J. Anderson Howard Hughes Medical Institute, California Institute of Technology Seymour Benzer Professor of Biology, Galien Forum USA The brain initiative
2018 John Andrianarisata Benin Country Office African Development Bank Country Manager Galien Forum Africa Addressing chronic malnutrition
2021 Mert Aral Huma Head of R&D & Clinical Strategy Galien Week of innovation Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2021 Juan Camilo Arjona Ferreira Myovant Sciences Ltd., Myovant Sciences, Inc. Chief Medical Officer Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2022 Katrina Armstrong Faculties of health sciences and the Vagelos college of physicians and surgeons & Columbia university Irving medical center Harold and Margaret hatch professor in the faculty of medicine Executive vice president for health and biomedical sciences - Dean & CEO Galien Forum USA - Chair Diversity and health equity in the future creation of medicine
2021 Scott A. Armstrong Dana-Farber Cancer Institute President, Boston Children’s Cancer & Blood Disorders Center; Chairman, Department of Pediatric Oncology, Galien Forum USA New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2015 David Artis Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College Cornell University, Joan & Sanford I. Weill Michael Kors Professor of Immunology Director, Department of Medicine Galien Forum USA Microbiota in human diseases
2021 El Hadji As Sy Kofi Annan Foundation International – Senegal President Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2018 El Hadji As Sy International Federation of Red Cross & Red Crescent Societies Secretary General Galien Forum Africa Financing africa’s healthcare
2022 Simon Ashwell GSK Global Corporate Affairs and Sustainability Galien Webinars Series Golden Jubilee - Best Vaccine Category
2020 Paul Atlan University Paris-Descartes, France Director of Teaching of Transcultural Biomedical Ethics Jerusalem Ethics Forum Up-to-date reflection on society, medicine & reproduction
2019 Paul  Atlan University Paris-Descartes, France Director of Teaching of Transcultural Biomedical Ethics Jerusalem Ethics Forum Personalized genomics medicine: the value of knowing
2013 Christopher Austin National Center for Advancing Translational Sciences, National Institutes of Health Director Galien Forum USA The promise of gene therapy
2015 Richard Axel the Kavli Institute for Brain Science, Columbia University Medical Center, New York Nobel Laureate, Co-Director Galien Forum USA Untangling the web of neurodegeneration: how far & how soon?
2014 Richard Axel the Kavli Institute for Brain Science, Columbia University Medical Centre, New York Nobel Laureate, Co-Director Galien Forum USA The brain initiative
2021 Maëlle Ba Speak Up Africa Strategic Communications Manager, Galien Forum Africa Leadership & innovation, meet the winners of the africa young innovators award for health
2021 Doudou Ba Academy of Sciences & Techniques of Senegal President Galien Forum Africa Conference on reform in health training
2021 Mamadou Ba Leadership & Management – Senegal Institutional Capacity Building Advisor Galien Forum Africa Youth leadership training (part 1)
2021 Mamadou Ba Leadership & Management – Senegal Institutional Capacity Building Advisor Galien Forum Africa Youth leadership training
2020 Alassane Ba Humanitarian Center for Pharmacy Trades (CHMP France) Director Galien Forum Africa Covid 19 drug supply chain in africa: challenges & perspectives
2015 Peter Bach Center for Health Policy & Outcomes, Memorial Sloan-Kettering Cancer Center Director Galien Forum USA Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2020 Junaid Bajwa Microsoft Chief Medical Scientist Galien Webinars Series Digital health in the aftermath of covid-19
2014 Andre-Michel Ballester Sorin group CEO Galien Foum Monaco Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021 Jeffrey Balser Vanderbilt University Medical Center President & Chief Executive Officer Galien Webinars Series The incubators of innovation: academic medical centers as digital health champions
2021 Stephane Bancel Moderna Chief Executive Officer Galien Forum USA Covid-19 vaccine development & the enduring impact on life sciences innovation – speed, collaboration, clinical trial advancement & manufacturing
2020 Stephane Bancel Moderna Chief Executive Officer Galien Forum USA Covid-19 vaccines: the path to the holy grail
2014 Cori Bargmann The Rockefeller University, New York Professor Galien Forum USA Keynote: fixed circuits & flexible behaviors
2022 Eliav Barr Merck research laboratories head, global clinical development & chief medical officer, Galien Forum USA Diversity and health equity in the future creation of medicine
2018 Françoise Barre-Sinoussi Director of the Regulation Retroviral Infections Division Professor Institut Pasteur Paris, France Nobel Prize for Medicine Galien Forum Africa Remarkable women engage for humanity
2018 Françoise Barre-Sinoussi Institut Pasteur - France Nobel Prize for Medicine Galien Forum Africa Plenary Panel - women in stem in africa
2018 Françoise Barre-Sinoussi Institut Pasteur - France Nobel Prize for Medicine Galien Forum Africa managing infectious diseases & pandemics
2021 Danny Bar-Zohar Merck KGaA Global Head of Development Galien Forum USA New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2017 Jose Baselga Memorial Sloan Kettering Cancer Center GRAIL, Inc. Physician-in-Chief & Chief Medical Officer, Director, Board of Directors, Galien Forum USA Addressing unmet medical needs with early-stage life science venture capital
2021 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2021 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Webinars Series The incubators of innovation: academic medical centers as digital health champions
2021 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Webinars Series Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Webinars Series The digital health enterprise: start-up trends & the culture of big pharma
2020 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Webinars Series Digital health webinar – presentation of the nominees in the 2020 prix galien digital health category
2020 Gil Bashe Finn Partners Managing Partner, Chair Global Health Galien Webinars Series Digital health in the aftermath of covid-19
2022 Gil Bashe Finn Chair Glob. Health&Purp. Moderator: Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020 Emmanuel Bassene Ministry of Health & Social Action (Senegal) Associate of Pharmacognosy & Head of the Traditional Medicine Division Galien Forum Africa Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5:
2020 Nathan Belete Senegal, Mauritania, Guinea Bissau, Gambia & Republic of Cape Verde, World Bank Director of Operations Galien Forum Africa Socio-economic impact of the covid 19 pandemic sub-theme 3
2021 Karim Bendhaou IFPMA Representative Galien Forum Africa Leadership & innovation, meet the winners of the africa young innovators award for health
2021 Christoph  Benn Global Health Diplomacy Director Galien Forum Africa Innovations & ethic for global health security
2015 Frank Bennett Ionis Pharmaceuticals Senior Vice-President of Research, Galien Forum USA Spinal muscular atrophy: charting the pathway to clinical progress
2019 Zion  Ben-Rafael Rabin Maj Center’s Campus Beilinson & Golda, Israel Director of the Department of Obstetrics & Gynecology Jerusalem Ethics Forum Human reproduction: technical limit, ethical limit
2020 Bjarne Bergheim Sonendo, Inc President & Chief Executive Officer Galien Week of innovation What is medtech innovation doing for patients with specialized needs for treatment?
2011 Jeffrey Berkowitz Walgreens Senior Vice President Pharmaceutical Development & Market Access Galien Forum USA What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2014 Emily Bernstein Icahn School of Medicine at Mount Sinai Prize Winner & Associate Professor of Oncological Sciences & Dermatology, Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2021 Rachele Berria AstraZenica Vice President & Medical Heads US Biopharmaceuticals Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 2
2021 Rachele Berria AstraZenica US Vice President & Medical Head Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19
2020 Uri Bettesh Datos-Health Chief Executive Officer Galien Webinars Series Digital health in the aftermath of covid-19
2020 Sailaja Bhaskar Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P. Executive Director, Clinical Operations Planning Galien Week of innovation The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2022 Sangeeta Bhorade Natera, Inc. CMO, Organ Health Division Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2020 Satasuk Joy Bhosai Duke Clinical Research Institute Chief of Digital Health & Strategy Galien Webinars Series Digital health improving research & care
2014 Francis Bidault Esmt European Xchool of Management and Technology Professor Galien Foum Monaco Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021 Agnes Binagwaho Global Health Equity University, The Global Health Equity University, Former Minister of Health of Rwanda Chancellor Galien Forum Africa Conference on reform in health training
2021 Agnes Binagwaho Global Health Equity University, Former Minister of Health of Rwanda Chancellor Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020 Fatou Binetou Sarr UFR Thies; Laureate of the Macky SALL Gr& Prize for Innovation (Senegal) Teacher & Researcher Galien Forum Africa Place of women in innovation related to covid 19 sub-theme 2:
2018 Kathie M. Bishop Otonomy Chief Executive Officer Galien Forum USA Spinal muscular atrophy: charting the pathway to clinical progress
2022 Andy Blackwell Ieso Digital Health Chief Science & Strategy Officer Galien Forum UK Digital health innovation: a key driver of next generation healthcare – what & when?
2015 Cheryl R. Blanchard Microchips Biotech, Inc. Chief Executive Officer Galien Forum USA Us health reform: partnering, pricing & politics
2015 Cheryl R. Blanchard Microchips Biotech, Inc. Chief Executive Officer Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2022 Robert O. Blaustein Merck & Co., Inc AVP Global Clinical Devt Galien Week of Innovation Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2017 Carina Blomström-Lundqvist Uppsala University Professor of Cardiology Galien Forum USA Atrial fibrillation
2014 Jeff Bluestone Provost at UCSF Immunology & Head of the Diabetes Center, Galien Forum USA Cancer immunotherapeutics
2021 Boris Bogdan Accenture Global Lead Medical Galien Week of innovation What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2022 François-Henri Boissel Novadiscovery Cofounder CEO Novadiscovery Galien Week of Innovation Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2016 Michael W. Bonney Cubist Pharmaceuticals Inc.; Advisor, UK Review on Antimicrobial Resistance Retired Chief Executive Officer, Galien Forum USA Next generation antimicrobials – shaping policy to develop new business models
2022 Marc Bonten Royal Netherlands Academy of Arts and Sciences (KNAW) Professor Galien Forum Netherlands #VALUE!
2018 Alexis Borisy Third Rock Ventures Partner Galien Forum USA Cancer in a time of disruption
2015 Alexis Borisy Third Rock Ventures Partner Galien Forum USA Autism - the next decade
2021 Ouided Bouchamaoui Tunisian Union of Industry, Commerce & Handicrafts Peace Nobel Prize Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2021 Ouided Bouchamaoui Honorary Committee of the Prix Galien Afrique Nobel Prize for Peace Galien Forum Africa Closing ceremony
2020 Ouided Bouchamaoui Tunisian Union of Industry, Commerce & Handicrafts Peace Nobel Prize Galien Forum Africa Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2018 Ouided Bouchamaoui Tunisian Union of Industry, Commerce & Handicrafts Peace Nobel Prize Galien Forum Africa Plenary Panel - women in stem in africa
2019 Albert Bourla Pfizer Inc. Chairman & Chief Executive Officer Galien Forum USA How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2021 Albert Bourla Pfizer Inc. Chairman & Chief Executive Officer Galien Forum USA Covid-19 vaccine development & the enduring impact on life sciences innovation – speed, collaboration, clinical trial advancement & manufacturing
2020 Abdoulaye Bousso Senegal Emergency Health Operations Center Director Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2013 Marc M. Boutin National Health Council Chief Executive Officer Galien Forum USA What’s holding back the technology revolution in clinical trials?
2014 Gilles Bouvenot National Academy of Medicine Member Galien Foum Monaco Innovation at what cost? make the voice of science and reason heard
2013 Robert Bradway Amgen Chairman & Chief Executive Officer Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2021 Vincent Bretin UNITAID International, France Director of Results Galien Forum Africa « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2013 Karin Briner Novartis Vice President & Head, Global Discovery Chemistry, Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2020 Sabine Brookman-May Janssen Research & Development, LLC Executive Medical Director, Late Development, Solid Tumor Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2022 Melissa Brotz Abbott Laboratories Chief Marketing & Communications Officer Galien Webinars Series Golden Jubilee - Best MedTech Category
2018 Denis Broun CIPLA Head of Government Affairs, Galien Forum Africa Universal access to essential & others medicines
2014 Michael S. Brown UT Southwestern Medical Center at Dallas Nobel Laureate, Professor of Molecular Genetics & Internal Medicine Galien Forum USA Heart attack guidelines
2013 Michael S. Brown UT Southwestern Medical Center at Dallas Nobel Laureate, Professor of Molecular Genetics & Internal Medicine Galien Forum USA Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2013 Paula Brown Novan, Inc. University of North Carolina, Chapel Hill, Co-Founder of Habergeon LLC Chief Development Officer,Professor of Public Health Leadership Galien Forum USA What’s holding back the technology revolution in clinical trials?
2021 Jason Brubaker Blueprint Medicines Vice President Medicinal Chemistry Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021 Anne Bruinvels Px HealthCare Chief Executive Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021 James Kyle Bryan IQVIA Biotech Chief Medical Officer Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2022 Aby Buchbinder Global Program Head Galien Week of Innovation Laureates Media Presentation
2022 Ulrike K Buchwald Merck & Co., Inc Executive Director, Global Clinical Development, Vaccine Galien Week of Innovation Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2013 Samantha Budd Neuroscience iMed at AstraZeneca R&D Vice President Galien Forum USA Neurodegenerative disease drug progress
2022 Heather Bukant Edwards Lifesciences Director, Global Communications Galien Webinars Series Golden Jubilee - Best MedTech Category
2022 Koos Burggraaf Centre for Human Drug Research (CHDR) CEO Galien Forum Netherlands #VALUE!
2022 Paul Burton Moderna Chief Medical Officer Galien Forum USA Covid pandemic science 2022: current vaccines and treatments and the future outlook
2021 Amy K. Butler Thermo Fisher Scientific Vice President & General Manager of Cell Biology, Galien Forum USA The marriage of technology & medicine: bringing out the best in each other
2016 Sean Caffey Replenish, Inc. Co-Founder, Chairman, & Chief Executive Officer of Auricle, LLC. Co-Founder & Chairman Galien Forum USA Next generation antimicrobials – shaping policy to develop new business models
2015 Sean Caffey Replenish, Inc. Co-Founder, Chairman, & Chief Executive Officer of Auricle, LLC. Co-Founder & Chairman Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2022 Giovanni Caforio Bristol Myers Squibb Chairman & Chief Executive Officer Galien Forum USA CEO Panel
2022 Robert M. Califf Food and drug administration Commissioner Galien Forum USA Keynote
2021 Robert M Califf Verify & Google Health; Adjunct Professor, Duke University & Stanford University; Former FDA Deputy Commissioner to President Barack Obama Head of Clinical Policy & Strategy, Galien Forum USA The future is decentralized -- how the paradigm has changed & what it means for modern trials
2013 Robert M. Califf Clinical & Translational Medicine, Director of the Duke Translational Medicine Institute (DTMI), & Professor of Medicine in the Division of Cardiology Duke University Vice Chancellor Galien Forum USA The promise of gene therapy
2017 John Camm St George’s, University of London Professor of Clinical Cardiology Galien Forum USA Atrial fibrillation
2020 Monique Canto-Sperber CNRS, France Director of Research Jerusalem Ethics Forum Up-to-date reflection on society, medicine & reproduction
2019 Monique Canto-Sperber CNRS, France Director of Research Jerusalem Ethics Forum Human reproduction: technical limit, ethical limit
2022 Renaud Capdeville, MD Novartis Global Program Head AML Galien Week of Innovation Laureates Media Presentation
2012 John Castellani Pharmaceutical Research Manufacturers of America (PhRMA) President & Chief Executive Officer Galien Forum USA 21st century science: building partnerships, managing for success
2021 Jeffrey P. Castelli Amicus Therapeutics Chief Development Officer Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2021 Cecile Cecile Association of Burkinabe Women Lawyers Lawyers Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2021 Eric Chan Teva Pharmaceuticals Director of Product Management in Digital Health Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2010 Paul Chew Sanofi-Aventis US Safety Signal Detection: The Promise & the Pitfalls“ Senior Vice President,Chief Scientific Officer/Chief Medical Officer, Dr. Galien Forum USA The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2020 Moredreck Chibi WHO Africa Regional Office Innovations Program Officer Galien Forum Africa Youth forum: leadership & young people facing covid-19
2020 Moredreck Chibi WHO Africa Regional Office Innovation Program Officer Galien Forum Africa What place for digital health & innovations? sub-theme 3:
2019 Beatrice  Childs France Psychoanalyst Jerusalem Ethics Forum Personalized genomics medicine: the value of knowing
2021 Herve Chneiweiss CNRS Neurolugue Director de Resercher Galien Webinars Series The impact of digital technology in clinical trials: ethical considerations (french edition)
2020 Mohamed Khaled Chouli Large Social Organizations (Morocco) Head of Department of Pre-clinical Sciences & Manager Galien Forum Africa Covid 19 drug supply chain in africa: challenges & perspectives
2021 Khady Cisse Organization for the Health of Children & Women – Cote d’Ivoire President Galien Forum Africa The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2021 Alessio Ciulli University of Dundee Professor of Chemical & Structural Biology, School of Life Sciences, Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2021 Tony Clapsis CVS Clinical Trial Services Vice President Galien Forum USA The future is decentralized -- how the paradigm has changed & what it means for modern trials
2020 Helen Clark EITI International President Galien Forum Africa Impact of the covid 19 pandemic on the natural resources sector sub-theme 2:
2022 Christine Clemson Albireo Pharma, Inc. SVP, Global Head of Medical Affairs Galien Week of Innovation BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021 Ron Cohen Acorda Therapeutics, Inc. President & Chief Executive Officer Jerusalem Ethics Forum The ethical obligations of pharmaceutical companies in a global health emergency – case study: covid-19 vaccines
2021 Bruno Cohen The Galien Foundation Chairman Galien Forum Africa Youth leadership training (part 1)
2021 Bruno Cohen The Galien Foundation Chairman Galien Forum Africa Youth leadership training
2021 Bruno Cohen The Galien Foundation Chairman Galien Forum Africa Inaugural Panel
2021 Bruno Cohen The Galien Foundation Chairman Galien Forum Africa Closing ceremony
2020 Brigitte Fanny Cohen Media Journalist Jerusalem Ethics Forum Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2010 Ron Cohen Acorda Therapeutics President & Chief Executive Officer Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2022 Ron Cohen Acorda President & CEO - Moderator Galien Week of Innovation Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2022 Heidi Cole GT Medical Technologies, Inc. Ass VP, R&D GT Medical Technologies Galien Week of Innovation Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2021 Awa Marie Coll Seck CN-ITIE Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Youth leadership training (part 1)
2021 Awa Marie Coll Seck CN-ITIE Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Youth leadership training
2021 Awa Marie Coll Seck Minister of State (Senegal) Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Women & stem in the global health security context
2021 Awa Marie Coll Seck President of NC-EITI, President of the Scientific Committee Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2021 Awa Marie Coll Seck President of NC-EITI, President of the Scientific Committee Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Inaugural Panel
2021 Awa Marie Coll Seck NC-EITI, Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Closing ceremony
2018 Awa Marie Coll Seck CN-ITIE Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Which plan for non communicable diseases?
2018 Awa Marie Coll Seck CN-ITIE Minister of State, President of the CN-ITIE, President of the Scientific Committee Galien Forum Africa Remarkable women engage for humanity
2022 Steven Collens MATTER CEO Galien Week of Innovation Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2020 Beth-Ann Coller Merck & Co., Inc Executive Director, Global Clinical Development Galien Week of innovation Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2014 Rory Collins the University of Oxford's Clinical Trials Unit Co-Director Galien Forum USA Heart attack guidelines
2018 Bernard Colombo Roche Diagnostics France Chairman Galien Forum Africa Which plan for non communicable diseases?
2012 Meryl Comer Geoffrey Beene Foundation Alzheimer's Initiative President  Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2021 Celestin Compaore DMPA-SC Project, Jhpiego 6 International Regional Director Galien Forum Africa The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2020 Brian S. Conklin Edwards Lifesciences Senior Distinguished Engineer Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2021 Vlad Coric Biohaven Pharmaceuticals Chief Executive Officer Galien Week of innovation What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2022 Mark Cornfeld Incyte Corp. VP Hemato. Onco. Clinical Det Galien Week of Innovation Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2020 Toumani Corrah African Research Excellence Fund (AREF) (London - Gambia- USA) Executive Director Galien Forum Africa Research facing covid 19
2018 Tumani Corrah AREF, Gambie Chief Executive Officer Galien Forum Africa Financing africa’s healthcare
2022 Christopher Corsico GSK Global Head of Development Galien Forum UK Clinical trials & regulations: what have we learned from covid?
2020 Sophie Coulbary Association of Women Doctors of Senegal AFEMS (Senegal) President Galien Forum Africa Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2022 Joseph Coulloc'h AAZ-LMb Founder & President Galien Webinars Series Golden Jubilee - Best MedTech Category
2022 Angela Coxon, Amgen VP Research Galien Week of Innovation Laureates Media Presentation
2012 Craig Crews John C. Malone Professor of Molecular, Cellular, & Developmental Biology, Yale University Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2020 Dan Cua Janssen Biotech, Inc. Vice President IL-23 Pathway Area Leader for the Immunology Therapeutic Area Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2022 Tom Daniel Scripps Research Institute MD Board of Directors Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2011 Stephen Daniels Hospital Colorado Pediatrician-in-Chief, University of Colorado School of Medicine, L Joseph, Butterfield Chair in Pediatrics Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2012 Alice Dautry Institut Pasteur President  Galien Forum USA Infectious diseases: a global healthcare challenge
2019 Benjamin  David Pouah Center Israel Medical Ethics Doctor Jerusalem Ethics Forum Personalized genomics medicine: the value of knowing
2019 Benjamin David Pouah Center Israel Medical Ethics Doctor Jerusalem Ethics Forum Ethical considerations around patient choice & human enhancement in healthcare?
2011 Brett Davis Oracle Corporation, Senior Director, Personalized Healthcare, Health Sciences Global Business Unit Galien Forum USA The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2022 Rob Davis Merck & co. CEO & president, Galien Forum USA CEO Panel
2015 Geraldine Dawson Duke Center for Autism & Brain Development, Duke University School of Medicine Professor, Department of Psychiatry & Behavioral Sciences & Director, Galien Forum USA Autism - the next decade
2021 Steph De Bono Eli Lilly & Company Senior Medical Director Galien Week of innovation What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2012 Neil De Crescenzo Oracle Health Sciences Senior Vice President & General Manager, Galien Forum USA Welcome Remarks
2022 Adam De la Zerda Visby Medical, Inc. Founder and CEO Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2021 Rui De Passos Sousa Sanofi Global Medical Head for the TTP program Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2020 Darryl De Vivo Columbia University Medical Center Sidney Carter Professor of Neurology & Pediatrics, Galien Forum USA Spinal muscular atrophy: charting the pathway to clinical progress
2014 Laurent Degos University of Paris Diderot & National Academy of Medicine Member Galien Foum Monaco Innovation at what cost? make the voice of science and reason heard
2014 Karl Deisseroth Stanford University Chen Professor of Bioengineering & of Psychiatry & Behavioral Sciences, Galien Forum USA The brain initiative
2020 Bernard Delaey Sanofi Regulatory Therapeutic Area Lead Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2018 George D. Demetri Dana-Farber Cancer Institute Ludwig Center, Harvard Medical School; Associate Director for Clinical Sciences, Dana Senior Vice President for Experimental Therapeutics, Professor of Medicine & Director Galien Forum USA Cancer in a time of disruption
2022 Bela Denes Lantheus VP Global Medical Affairs Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2011 Alex Depaoli NGM Biopharmaceuticals Vice President of Translational Research, Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2015 Nancy-Ann Deparle Consonance Capital Partners Partner Galien Forum USA Us health reform: partnering, pricing & politics
2021 Sue Desmond-Hellmann Bill & Melinda Gates Foundation Prix Galien Committee Chair & Former Chief Executive Officer Galien Forum USA Vaccines, drugs & the future of pandemics - - lessons from covid-19
2020 Sue Desmond-Hellmann Bill & Melinda Gates Foundation Prix Galien Committee Chair & Former Chief Executive Officer Galien Forum USA The next 50 years of innovation: where will it come from & how do we secure it?
2020 Sue Desmond-Hellmann Bill & Melinda Gates Foundation Prix Galien Committee Chair & Former Chief Executive Officer Galien Forum Africa Research funding: state of play & perspectives sub-theme 4:
2020 Sue Desmond-Hellmann Bill & Melinda Gates Foundation Prix Galien Committee Chair & Former Chief Executive Officer Galien Forum Africa Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2020 Sue Desmond-Hellmann Bill & Melinda Gates Foundation Prix Galien Committee Chair & Former Chief Executive Officer Galien Forum USA Closing remarks
2018 Sue Desmond-Hellmann Bill & Melinda Gates Foundation Prix Galien Committee Chair & Former Chief Executive Officer Galien Forum Africa Remarkable women engage for humanity
2021 Deepika  Devadas Grand Challenges Canada Senior Program Advisor Galien Forum Africa Meeting of young innovators with investors
2022 Nina Devlin Vertex SVP & Chief Communciations Officer Galien Webinars Series Golden Jubilee - Best Orphan Rare Category
2020 Djiby Diagne Emerging Senegal Plan (BOS - PSE) (Senegal) Operational Monitoring Office Galien Forum Africa Place of local production in the pharmaceutical sector sub-theme 4:
2021 Djiby Diakhate National Council for Audiovisual Regulation CNRA – Senegal Sociologist teacher Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2021 Adja Diakhou Ndiaye High Council on Health Security, One Health – Senegal Permanent Secretary Galien Forum Africa Women’s leadership in global health security
2021 Ndeye Fatou Diallo Neighborhood godmother (Senegal), Neighborhood godmother Galien Forum Africa Women’s leadership in global health security
2021 Mohamadou Diallo CIO Mag Founder & Editor in Chief Galien Forum Africa Women & stem in the global health security context
2021 Abdourahmane Diallo Roll Back Malaria International – Guinea Director Galien Forum Africa « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2018 Abdourahmane Diallo Presidency of the Republic of Guinea, Minister Counselor in charge of Health Issues Director, Minister Counselor Galien Forum Africa Universal access to essential & others medicines
2017 Marc Diamond Center for Alzheimer’s & Neurodegenerative Disease, the University of Texas, Southwestern Medical Center Distinguished Chair in Basic Brain Injury & Repair & Director, Galien Forum USA Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020 Oley Dibba Wadda GAM African Leadership Institute (Gambia) President Galien Forum Africa Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2013 Andrew Dillon National Institute for Health & Care Excellence (NICE), Chief Executive Galien Forum USA Making medicines affordable
2021 Ibrahima Cheikh Diong United NationsDirector General of ARC – International – Senegal Assistant Secretary-General Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2021 Amadou Gallo Diop Research &  Innovation – MESRI Platform Director General Galien Forum Africa Innovations & ethic for global health security
2020 Amadou Gallo Diop Research Ministry of Higher Education, Research & Innovation (Senegal) Director General Galien Forum Africa Research funding: state of play & perspectives sub-theme 4:
2021 Waly  Diouf DANGOTE Cement Senegal Director of Human Resources Galien Forum Africa Meeting of young innovators with investors
2021 Abdoulaye Diouf Sarr Minister of Health & Social Action Senegal Minister of Health Galien Forum Africa « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2018 Abdoulaye Diouf Sarr Senegal Minister of Health Galien Forum Africa Financing africa’s healthcare
2022 Graham Dixon Mayne Pharma Chief Scientific Officer Galien Week of Innovation Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2021 Yacine  Djibo Speak Up Africa Founder & Executive Director Galien Forum Africa Women & stem in the global health security context
2020 Yacine Djibo Speak Up Africa Founder & Executive Director Galien Forum Africa Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4:
2022 Mikael Dolsten Pfizer Inc Chief Scientific Officer & President, Worldwide Research Galien Forum USA - Chair Covid pandemic science 2022: current vaccines and treatments and the future outlook
2021 Mikael Dolsten Pfizer Inc Chief Scientific Officer & President, Worldwide Research Galien Forum USA Where will new therapies & vaccines come from?
2020 Mikael Dolsten Pfizer Inc Chief Scientific Officer & President, Worldwide Research Galien Forum USA The promise of gene therapy
2020 Mikael Dolsten Pfizer Inc Chief Scientific Officer & President, Worldwide Research Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2020 Mikael Dolsten Pfizer Inc Chief Scientific Officer & President, Worldwide Research Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2017 Mikael Dolsten Pfizer Inc. Chief Scientific Officer & President, Worldwide Research Galien Forum USA Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2016 Mikael Dolsten Pfizer Inc. Chief Scientific Officer & President, Worldwide Research Galien Forum USA Precision medicine: delivering on the promise
2014 Mikael Dolsten Pfizer Inc. Chief Scientific Officer & President, Worldwide Research Galien Forum USA A new agenda for global health
2013 Mikael Dolsten Pfizer Inc Chief Scientific Officer & President, Worldwide Research Galien Forum USA Improving efficiency in drug development
2021 Habib Douagui Algerian Society of Asthmology, Allergology & Clinical Immunology (SAAIC); Member of the Executive Committee of Respiratory Diseases & Allergies at the World Allergy Organization (WAO) International – Algeria President Galien Forum Africa « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2020 Philippe Douste-Blazy United Nations Deputy General Secretary Jerusalem Ethics Forum Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2019 Philippe Douste-Blazy United Nations Deputy General Secretary Jerusalem Ethics Forum Health policy & financing innovation: ethical considerations, cost & the role of the patient
2019 Philippe Douste-Blazy United Nations Deputy General Secretary Jerusalem Ethics Forum 2020/2030 agenda “facing the next ethical challenges”
2018 Philippe Douste-Blazy United Nations Deputy General Secretary Galien Forum Africa Which health insurance for the african continent?
2018 Philippe Douste-Blazy United Nations Deputy General Secretary Galien Forum Africa Which health insurance for the african continent?
2022 Cristal Downing Merck & Co Executive Vice President & Chief Communications and Public Affairs Officer Galien Webinars Series Golden Jubilee - Best Pharmaceutical Category
2015 William F. Doyle NovoCure, Ltd. Executive Chairman Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2019 Nancy Dreyer IQVIA Chief Scientific Officer Galien Forum USA Digital health -orchestrating patient- centricity from molecule to market
2016 Daniel J. Drucker Research Institute Mt. Sinai Hospital Toronto Ontario, Canada Senior Scientist, Lunenfeld Tanenbaum Galien Forum USA Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2020 Philippe Duneton United Nations Executive Director Galien Forum Africa Place of local production in the pharmaceutical sector sub-theme 4:
2018 Philippe Duneton UNITAID Director Galien Forum Africa Universal access to essential & others medicines
2022 Adam Dunki-Jacobs Standard Bariatrics, Inc. Titan SGS® Galien Week of Innovation Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2021 Cristina Duran AstraZeneca Chief Digital Health Officer, R&D Galien Forum USA The future is decentralized -- how the paradigm has changed & what it means for modern trials
2022 Tim Durst Accenture Global Medical Technology Sector Lead - Moderator Galien Week of Innovation Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2014 Gerard Duru CNRS Honorary Research Director Galien Foum Monaco Innovation at what cost? make the voice of science and reason heard
2021 Mette Dyhrberg Mymee Founder & Chief Executive Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Craig Eagle Guardant Health CMO Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2021 Jamey Edwards Cloudbreak Health Chief Executive Officer Galien Webinars Series Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020 Mark Milton Edwards Teva Pharmaceutical Industries Head of Product & Health Solutions – Digital Health Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2020 Pierre Effa Pan-African Ethics & Bioethics Congress (COPAB) President Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2020 Serge Eholie Ivory Coast Head of the ALERRT work platform Galien Forum Africa Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3:
2010 Paul Eisenberg Amgen Strategies for Incorporating Continuous Benefit: Risk into Drug Developmen Global Regulatory Affairs & Safety Galien Forum USA The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2022 Sathya Elumalai Aidar Health President & CEO Aidar Health Galien Week of Innovation Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2021 Ezekiel J. Emanuel University of Pennsylvania Vice Provost for Global Initiatives & Professor & Co-Director, Healthcare Transformation Institute Jerusalem Ethics Forum The ethical obligations of pharmaceutical companies in a global health emergency – case study: covid-19 vaccines
2014 Ezekiel J. Emanuel University Professor Perelman School of Medicine & The Wharton School University of Pennsylvania Vice Provost for Global Initiatives, Chair, Department of Medical Ethics & Health Policy Levy Galien Forum USA Us health reform
2019 David R. Epstein Flagship Pioneering Executive Partner Galien Forum USA What’s holding back the technology revolution in clinical trials?
2017 David Epstein Novartis Pharmaceuticals Former Chief Executive Officer & Division Head Galien Forum USA Moderator
2016 David Epstein Novartis Pharmaceuticals Former Chief Executive Officer & Division Head Galien Forum USA Promise - & politics - in the fight against cancer
2016 David Epstein Novartis Pharmaceuticals Former Chief Executive Officer & Division Head Galien Forum USA Promise - & politics - in the fight against cancer
2011 Robert S. Epstein Medco Health Solutions, Inc. Chief Clinical Research & Development Officer Galien Forum USA What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021 Barış Erdoğan Clinerion Chief Executive Officer Galien Week of innovation Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2020 Daniel Everitt TB Alliance Vice President & Chief Medical Officer Galien Week of innovation Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2021 Ibrahima Soce Fall Emergency Response at WHO International – Senegal Assistant Director-General Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 6
2020 Ibrahima Soce Fall Emergency Response (WHO-Geneva) Assistant Director-General Galien Forum Africa Health break
2021 Barbara  Fant Clinical Research Consultants, Inc. President Galien Week of innovation What is med tech innovation doing for patients with specialized needs for treatment?
2020 Barbara Fant Clinical Research Consultants, Inc. President Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2021 Anthony S. Fauci NIAID & Chief Advisor to the President of the United States Director Galien Forum USA Keynote
2021 Anthony S. Fauci NIAID & Chief Advisor to the President of the United States Director Galien Forum USA Galien golden jubilee special address
2022 Anthony S. Fauci NIAID & chief advisor to the president of the united states Director Galien Forum USA Special Address Galien Golden Jubilee
2021 Olufunmilayo Fawole Faculty of Public Health at the University of Ibadan – Nigeria Epidemiologist & Dean Galien Forum Africa Involvement of women researchers in the mhw
2021 Jessica Federer Bayer Partner Boston Millenia Partners Former CDO Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2021 Jessica Federer Bayer Partner Boston Millenia Partners Former CDO Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 3
2021 Jessica Federer Bayer Partner Boston Millenia Partners Former CDO Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19
2021 Jessica Federer Bayer, HUMA Managing Director; HUMA Former Chief Digital Officer Galien Webinars Series Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020 Jessica Federer Bayer Partner Boston Millenia Partners Former CDO Galien Webinars Series Digital health improving research & care
2022 Jessica Federer Supernode Ventures MP - Moderator Galien Week of Innovation Disease Diagnostics and Digital Therapeutics How far are we from achieving the health system world of the connected patient?
2022 Jessica Federer Supernode Ventures MP - Moderator Galien Week of Innovation Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2014 Mark Feinberg IAVI Chief Executive Officer Galien Forum USA Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2020 Marc Fellous Bayer Global Medical Affairs Head Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2016 David Feltquate Bristol-Myers Squibb Vice President, Immuno-Oncology Development, Galien Forum USA Precision medicine: delivering on the promise
2014 Adolfo Ferrando Institute for Cancer Genetics,Columbia University Medical Center Prize Winner & Associate Professor of Pediatrics & Pathology, Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2019 Mauro Ferrari Houston Methodist Research Institute,Houston Methodist Hospital System Ernest Cockrell Jr. Presidential Distinguished Chair, President & Chief Executive Officer, Executive Vice President, Galien Forum USA What’s holding back the technology revolution in clinical trials?
2019 Michael Fischbach Stanford University Associate Professor of Bioengineering Galien Forum USA The gut microbiome: opportunities & challenges
2021 Senait Fisseha Susan Thompson Buffett Foundation International – Ethiopia Director of International Programs Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2021 Senait Fisseha Susan Thompson Buffett Foundation International – Ethiopia Director of International Programs Galien Forum Africa Closing ceremony
2020 Senait Fisseha Susan Thompson Buffett Foundation International – Ethiopia Director of International Programs Galien Forum Africa Place of women in innovation related to covid 19 sub-theme 2:
2011 Martin Fitchet Johnson & Johnson, Pharmaceutical Research & Development Chief Operating Officer Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2018 Julian Fleet START-International (USA) Ethical specialist Galien Forum Africa The health consequences of climate change
2019 Emmanuel Fombu The Future of Healthcare Medical Futurist Galien Forum USA Digital health -orchestrating patient- centricity from molecule to market
2019 Emmanuel Fombu The Future of Healthcare Medical Futurist Jerusalem Ethics Forum “artificial intelligence & ethics”
2021 Joanne Micale Foody Esperion Chief Medical Officer Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2017 Jean Francois Formela Atlas Ventures Partner Galien Forum USA Addressing unmet medical needs with early-stage life science venture capital
2014 Richard N. Foster Healthcare Innovation, Yale University;Director Emeritus, McKinsey & Company Venture Partner, Lux Capital; Special Advisor to the President Galien Forum USA The future of digital health
2021 Jacqualyn Fouse Agios Chief Executive Officer Galien Forum USA How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2020 Susannah Fox U.S. Department of Health & Human Services Independent Consultant & Health Care Innovation Leader & Former Chief Technology Officer Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2021 Kenneth C. Frazier Merck & Co., Inc Chairman of the Board - President & Chief Executive Officer Galien Forum USA Keynote remarks & a discussion with
2020 Kenneth C. Frazier Merck & Co., Inc Chairman of the Board - President & Chief Executive Officer Galien Forum USA Combating the opioid crisis in america
2015 Bud Frazier Baylor College of Medicine & the University of Texas Health Science Center, Chief of the Center for Cardiac Support at The Texas Heart Institute Professor of Surgery Galien Forum USA Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2015 Kenneth C. Frazier Merck & Co., Inc Chairman of the Board - President & Chief Executive Officer Galien Forum USA Us health reform: partnering, pricing & politics
2013 Kenneth C. Frazier Merck & Co., Inc Chairman of the Board - President & Chief Executive Officer Galien Forum USA Affordable care act us healthcare in transition: the stakes for industry
2016 Maria C. Freire Foundation for the National Institutes of Health President & Executive Director Galien Forum USA Next generation antimicrobials – shaping policy to develop new business models
2012 Maria C. Freire Albert & Mary Lasker Foundation President  Galien Forum USA Infectious diseases: a global healthcare challenge
2022 Greg Friberg Amgen Inc. VP Medical Affairs ELMAC Region Galien Week of Innovation Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2011 Jeffrey Friedman Investigator Howard Hughes Medical Institute, Laboratory of Genetics, The Rockefeller University Marilyn M Simpson Professor Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2022 Johannes Fruehauf BioLabs Founder, President Galien Week of Innovation Laureates Media Presentation
2022 Johannes Fruehauf BioLabs and LabCentral Founder President Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020 Rene Frydman Antoine Beclere Hospital, France Head of the Department of Gynecology & Obstetrics Jerusalem Ethics Forum Up-to-date reflection on society, medicine & reproduction
2020 Rene Frydman Antoine Beclere Hospital, France Head of the Department of Gynecology & Obstetrics Jerusalem Ethics Forum Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2019 Rene Frydman Antoine Beclere Hospital, France Head of the Department of Gynecology & Obstetrics Jerusalem Ethics Forum Human reproduction: technical limit, ethical limit
2019 Rene Frydman Antoine Beclere Hospital, France Head of the Department of Gynecology & Obstetrics Jerusalem Ethics Forum 2020/2030 agenda “facing the next ethical challenges”
2012 Les Funtleyder Polliwog Fund Manager Galien Forum USA The changing face of chinese healthcare
2011 Les Funtleyder Miller Tabak Healthcare Strategist & Portfolio Manager, Health Care Transformation Fund Galien Forum USA Funding innovation new trends in the healthcare m&a l& scape
2012 John Furey Spark Therapeutics Inc. Chief Operating Officer Galien Forum USA Making medicines affordable
2019 Gilles Gade Cross River Founder, President & Chief Executive Officer Jerusalem Ethics Forum Health policy & financing innovation: ethical considerations, cost & the role of the patient
2019 Gilles Gade Cross River Founder, President & Chief Executive Officer Jerusalem Ethics Forum 2020/2030 agenda “facing the next ethical challenges”
2018 Priya Gajraj PNUD - Dakar Resident Representative Galien Forum Africa Which health insurance for the african continent?
2012 Diana Gallagher Biogen Head of External Innovation, Galien Forum USA Infectious diseases: a global healthcare challenge
2021 Pushkal Garg Alnylam Chief Medical Officer Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2020 Pushkal Garg Alnylam Chief Medical Officer Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2021 Diane Gashumba Former Minister of Health of Rwanda Ambassador Galien Forum Africa Women’s leadership in global health security
2020 Diane Gashumba Former Minister of Health of Rwanda Ambassador Galien Forum Africa Health & socio-economic impact of the covid 19 pandemic in africa sub-theme 1: resilience of health systems & continuity of care: state of play, challenges & rerspectives
2018 Diane Gashumba Former Minister of Health of Rwanda Ambassador Galien Forum Africa Which health insurance for the african continent?
2022 Natacha Gassenbach Biogen Head of Corporate Affairs, Chief Communications Officer Galien Webinars Series Golden Jubilee - Best Orphan Rare Category
2022 Judy Gawlik Brown Amgen SVP, Corporate Affairs Galien Webinars Series Golden Jubilee - Best Orphan Rare Category
2021 Julie Louise Gerberding Merck & Co., Inc. Chief Patient Officer & Executive Vice President, Population Health & Sustainability Jerusalem Ethics Forum Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2016 Julie Louise Gerberding Merck & Co., Inc. Executive Vice-President, Chief Patient Officer & Head of Policy Galien Forum USA Keynote
2015 Julie Louise Gerberding Merck & Co., Inc. Executive Vice-President, Chief Patient Officer & Head of Policy Galien Forum USA Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2012 Julie Louise Gerberding Merck Vaccines, Merck & Co., Inc.; Former Director, Centers for Disease Control & Prevention (CDC) President  Galien Forum USA Infectious diseases: a global healthcare challenge
2011 Barry Gertz Merck Senior Vice President, & head of clinical research & regulatory affairs Galien Forum USA What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021 Ken Getz Tufts Center for the Study of Drug DevelopmentTufts University School of Medicine Director Jerusalem Ethics Forum Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2021 Tedros A. Ghebreyesus WHO Director General Galien Forum Africa Inaugural Panel
2021 Tedros A. Ghebreyesus WHO Director General Galien Forum Africa Closing ceremony
2018 Tedros A. Ghebreyesus WHO (World Health Organization) Director General Galien Forum Africa Which health insurance for the african continent?
2018 Tedros A. Ghebreyesus World Health Organization Director General Galien Forum Africa Which health insurance for the african continent?
2020 Gargee Ghosh Bill & Melinda Gates Foundation Director of Development Policy & Finance Galien Forum Africa Financing the response to covid 19
2018 Gambie Gargee Ghosh Bill & Melinda Gates Foundation Director of Development Policy & Finance Galien Forum Africa Financing africa’s healthcare
2022 Mati Gill AION Labs CEO Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2014 Michael Giordano Oncology & Immunoscience at Bristol-Myers Squibb Senior Vice President, Head of Development, Galien Forum USA Cancer immunotherapeutics
2020 Nicanor Giorgio Austriaco Providence College Biology & Theology Jerusalem Ethics Forum Societal, legal & ethical challenges around access to covid-19 vaccines
2019 Nicanor Giorgio Austriaco Providence College Biology & Theology Jerusalem Ethics Forum Ethical considerations around patient choice & human enhancement in healthcare?
2020 Sophie Gladima Senegal Minister of Petroleum & Energy Galien Forum Africa Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2018 Sophie Gladima Siby Senegal Minister of Industries Galien Forum Africa Plenary Panel - women in stem in africa
2021 Laurie H. Glimcher Harvard Medical School President & Chief Executive Officer, Dana-Farber Cancer Institute, Richard & Susan Smith, Professor of Medicine, Galien Forum USA New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2015 Laurie H. Glimcher Cornell University, New York Dean of Weill Cornell Medical College & Provost for Medical Affairs Galien Forum USA Microbiota in human diseases
2014 Laurie H. Glimcher Cornell University Dean of Weill Cornell Medical College & Provost for Medical Affairs Galien Forum USA Cancer immunotherapeutics
2021 Claire Gloeckner Becton-Dickinson Senior Staff Scientist Galien Week of innovation What is med tech innovation doing for patients with specialized needs for treatment?
2014 Joseph Goldstein UT, Southwestern Medical Center at Dallas Nobel Laureate, Professor of Molecular Genetics & Internal Medicine, Galien Forum USA Heart attack guidelines
2013 Joseph Goldstein UT, Southwestern Medical Center at Dallas Nobel Laureate, Professor of Molecular Genetics & Internal Medicine, Galien Forum USA Personalized medicine: effect on drug r&d & patient care
2015 Jeff Gordon Robert Glaser University Center for Genome Sciences & Systems Biology at Washington University in St. Louis Professor & Director Galien Forum USA Microbiota in human diseases
2015 Jeff Gordon Robert Glaser University Center for Genome Sciences & Systems Biology at Washington University in St. Louis Professor & Director Galien Forum USA Keynote
2016 Alex Gorsky Johnson & Johnson Chairman of the Board - President & Chief Executive Officer Galien Forum USA Promise - & politics - in the fight against cancer
2013 Alex Gorsky Johnson & Johnson Chairman of the Board - President & Chief Executive Officer Galien Forum USA Affordable care act us healthcare in transition: the stakes for industry
2016 Scott Gottlieb Food & Drug Administration Former Commissioner of the U.S. Galien Forum USA Keynote dialogue life science companies: public health institutions or black hats?
2021 Raymonde Goudou Coffie Lakes District Former Minister of Health Ivory Coast Minister Governor Galien Forum Africa Women’s leadership in global health security
2020 Raymonde Goudou Coffie Lakes District Former Minister of Health Ivory Coast Minister Governor Galien Forum Africa Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2021 Ann M. Graybiel MIT Institute Professor, Department of Brain & Cognitive Science, Galien Forum USA Future pathways in translational medicine -- academic-industry collaborations in cns diseases
2010 Paul Greengard Rockefeller University Nobel Laureate Professor Galien Forum USA Translational neuroscience: academic-industrial collaborations in cns diseases
2016 Philip D. Gregory Bluebird Chief Scientific Officer Galien Forum USA The promise of gene therapy
2020 Jessica Grossman Medicines360 Chief Executive Officer Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2014 Dan Grossman Boston Consulting Group Managing Director & Senior Partner. Health Care Practice Area, Galien Forum USA A new agenda for global health
2014 Scott Grundy Texas Southwestern Medical Center; Center for Human Nutrition University Professor Galien Forum USA Heart attack guidelines
2021 Henri  Gueye EYONEInvestors Founder & Chief Executive Officer Galien Forum Africa Meeting of young innovators with investors
2021 Arame Gueye Sene Social Change Factory – Senegal Executive Director Galien Forum Africa The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2022 Vishal Gulati Deeptech / Healthtech VC Director Galien Forum UK Digital health innovation: a key driver of next generation healthcare – what & when?
2021 Ira Gupta GSK Vice President, Medicines Development Leader – Global Oncology Therapy Area Galien Week of innovation Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2020 Fred Guterl The Fate of the Species Author Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2021 Sebastian Guth Bayer Pharmaceuticals, Americas Region President  Galien Forum USA The future is decentralized -- how the paradigm has changed & what it means for modern trials
2020 Shwen Gwee Bristol Myers Squibb Vice President & Head of Global Digital Strategy Galien Webinars Series Digital health in the aftermath of covid-19
2012 Kimberly Ha Biopharm Insight Global Editor Galien Forum USA The changing face of chinese healthcare
2011 Kimberly Ha Biopharm Insight Global Editor Galien Forum USA Funding innovation new trends in the healthcare m&a l& scape
2021 Amir Aman Hagos Health of Ethiopia International – Ethiopia GFF Strategic Advisor Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 1
2022 William N. Hait Johnson & Johnson Global Head, Research & Development Galien Forum USA Diversity and health equity in the future creation of medicine
2014 William N. Hait Janssen Research & Development Global Head, Research & Development Galien Forum USA A new agenda for global health
2015 John Hambor Research Administration Boehringer Ingelheim Pharmaceuticals, Inc. Distinguished Research Fellow Galien Forum USA Microbiota in human diseases
2016 Margaret A. Hamburg Food & Drug Administration Former Commissioner of the U.S. Galien Forum USA Promise - & politics - in the fight against cancer
2015 Margaret A. Hamburg Food & Drug Administration Former U.S. Commissioner Galien Forum USA Delivering on the patient promise of gene therapy
2012 Margaret A. Hamburg U.S. Food & Drug Administration Commissioner, Galien Forum USA Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2012 Margaret A. Hamburg Food & Drug Administration Commissioner Galien Forum USA Infectious diseases: a global healthcare challenge
2018 Patrice A. Harris American Medical Association President-elect, Galien Forum USA Novel approaches to combatting opioid addiction
2021 Fatima Hassan Health Justice Initiative HJI – South Africa Founder Galien Forum Africa Innovations & ethic for global health security
2012 Fred Hassan Bausch & Lomb Chairman of the Board - President & Chief Executive Officer Galien Forum USA “looking back, moving forward”
2020 Richard Hatchett Coalition for Epidemic Preparedness Innovations Chief Executive Officer Galien Forum Africa Vaccine production: state of play & perspectives sub-theme 3
2020 Richard Hatchett Coalition for Epidemic Preparedness Innovations Chief Executive Officer Jerusalem Ethics Forum Societal, legal & ethical challenges around access to covid-19 vaccines
2019 Richard Hatchett Coalition for Epidemic Preparedness Innovations Chief Executive Officer Galien Forum USA Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2018 Richard Hatchett Coalition for Epidemic Preparedness Innovations Chief Executive Officer Galien Forum Africa Universal access to essential & others medicines
2022 Richard M. Haupt Merck Vice President Galien Week of Innovation Laureates Media Presentation
2020 David Hayes Biotronik Chief Medical Officer Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2020 Penny M. Heaton Bill & Melinda Gates Gates Medical Research Institute Chief Executive Officer Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2018 Michael Heffernan Collegium Pharmaceutical Chairman Galien Forum USA Novel approaches to combatting opioid addiction
2016 Michael Heffernan Collegium Pharmaceutical Chairman Galien Forum USA Next generation antimicrobials – shaping policy to develop new business models
2010 Thomas Heffner Pfizer Executive Director of Worldwide Business Development , Galien Forum USA Translational neuroscience: academic-industrial collaborations in cns diseases
2022 Kristen Hege Bristol Myers Squibb SVP Onco/Hemato /Cell Therapy Galien Week of Innovation Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2022 Nicky Hekster The Netherlands Independent freelance teacher Galien Forum Netherlands #VALUE!
2021 Marie-Pierre Hellio Le Graverand Pfizer Senior Vice President, Head of Clinical Development & Operations Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-20
2021 Marie-Pierre Hellio Le Graverand Pfizer Senior Vice President, Head of Clinical Development & Operations Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 4
2011 Hunt Henrie Ferghana Partners Managing Director a specialist investment banking group Galien Forum USA Funding innovation new trends in the healthcare m&a l& scape
2012 Karl Hick Takeda Chief Digital & Information Officer Galien Forum USA The promise of gene therapy
2013 Kathy A. High Spark Therapeutics President & Head of Research & Development Galien Forum USA Fireside chat | delivering on the patient promise of gene therapy
2012 Kathy High Spark Therapeutics President & Head of Research & Development Galien Forum USA The promise of gene therapy
2021 Samit Hirawat Bristol Myers Squibb Executive Vice President, Chief Medical Officer, Global Drug Development Galien Forum USA New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2012 R.T. (Terry) Hisey Deloitte LLP Vice Chairman & US Life Sciences Leader Galien Forum USA The changing face of chinese healthcare
2021 Colin Hislop Eiger Biopharmaceuticals Inc. Senior Vice President of Clinical & Development Operations Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2022 Colin Hislop Eiger BioPharmaceuticals, Inc. Sr VP Clinical&Devt Operations Galien Week of Innovation Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2022 John Hoekman Impel Pharmaceuticals Inc. Chf Technology & Devt Officer Galien Week of Innovation Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2021 Michelle Hoiseth Parexel International Chief Data Officer & Corporate Vice President Medical & Scientific Services Galien Webinars Series Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020 Michelle Hoiseth Parexel International Chief Data Officer & Corporate Vice President Medical & Scientific Services Galien Webinars Series Digital health improving research & care
2022 Alison Holland Medable Head of Decentralized Clinical Trials Galien Forum UK Clinical trials & regulations: what have we learned from covid?
2022 Ali Holland Medable Head of Decentralised Clinical Trials - Moderator Galien Week of Innovation Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2013 David Holtzman Disease Research Center, Washington University Andrew B. & Gretchen P. Jones Professor & Chairman, Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer‘s Galien Forum USA Neurodegenerative disease drug progress
2010 Peter Honig Astra Zeneca The New Postmarketing Pharmacovigilance Toolbox Head,Global Regulatory Affairs, Galien Forum USA The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2022 Andrew Hopkins,  Exscientia CEO Galien Week of Innovation Laureates Media Presentation
2013 Herve Hoppenot Novartis Oncology, Novartis Pharmaceuticals Corporation President Galien Forum USA Oncology: newer therapies
2020 Amadou Hott Planning & International Cooperation of Senegal Minister of Economy, Planning & Cooperation Galien Forum Africa Socio-economic impact of the covid 19 pandemic sub-theme 4
2021 Amadou  Hott  Planning & International Cooperation of Senegal Minister of Economy Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2016 John G. Houston Arvinas President & Chief Executive Officer Galien Forum USA Promise - & politics - in the fight against cancer
2022 Mary Howard Design Technologies LLC Program Director Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2016 Scott Howell Novartis Pharmaceuticals Inc. Vice-President & Head, US Market Access, Galien Forum USA Making medicines affordable
2021 Dennis E. Hruby SIGA Technologies, Inc. Chief Scientific Officer Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2020 Dennis E. Hruby SIGA Technologies, Inc. Chief Scientific Officer Galien Week of innovation Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2016 Clifford A. Hudis the American Society of Clinical Oncology Chief Executive Officer Galien Forum USA Promise - & politics - in the fight against cancer
2020 Mimi Huizinga Novartis Vice President & Head, US Oncology Medical Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2020 Mimi Huizinga Novartis Vice President & Head, US Oncology Medical Galien Week of innovation Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2012 Mark Hulse Moffitt Cancer Center RN, Vice President Information Technology & Chief Information Officer, Galien Forum USA The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2012 Stephen Hume Psy.D., Clinician & patient with early onset Alzheimer's disease Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2022 Robert Iannone Jazz Pharmaceuticals Global Head of R&D Galien Week of Innovation Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2021 Joseph Illa Ordre des Medecins - Burkina Faso Doctor Galien Forum Africa Conference on reform in health training
2021 Lucile Imboua WHO Senegal Resident Representative Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020 Lucile Imboua WHO Resident Representative Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2022 Bev Incledon Ironshore Pharmaceuticals Inc. CSO and Executive VP Galien Week of Innovation Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2020 Alon Iron THERANICA President & Chief Executive Officer, Co-founder Galien Webinars Series The digital health enterprise: start-up trends & the culture of big pharma
2021 Melanie Ivarsson Moderna Chief Development Officer Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 5
2012 Andrew Jack Financial Times, Journalist Galien Forum USA Moderator
2021 David Jacoby BioMarin Fellow for Clinical Sciences & Vice President Discovery Medicine Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2014 Sachin H. Jain Merck & Co Inc.; Lecturer in Healthcare Policy, Harvard Medical School Chief Medical information & Innovation Officer Galien Forum USA The future of digital health
2022 Petra Jantzer Accenture Senior managing director, global life sciences lead, Galien Forum USA - Chair CEO Panel
2021 Ted W. Johnson Medicinal Chemistry, Pfizer Oncology Pfizer Inc Research Fellow Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2020 Ted W. Johnson Medicinal Chemistry, Pfizer Oncology Pfizer Inc. Research Fellow Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2021 Russ Joseph Edwards Lifesciences Senior Director, Product Development, Transcatheter Heart Valves Galien Week of innovation How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2013 Kris Joshi Oracle Health Sciences Global Vice President, Healthcare Galien Forum USA Welcome & intro
2012 Kris Joshi Healthcare, Oracle Health Sciences Global Vice President, Galien Forum USA Addressing big datachallenges in genomics & personalized healthcare
2021 Marc Julien Diabeloop Co-Chief Executive Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021 Carl H. June Director of Translational Research at the Abramson Cancer Center the University of Pennsylvania Galien Forum USA Where will new therapies & vaccines come from?
2021 Carl H. June Center for Cellular - Immunotherapies - UPenn Director Galien Forum USA The future is decentralized -- how the paradigm has changed & what it means for modern trials
2021 Anne-Maryse K’Habore CAMEG General Manager of CAMEG – SG of ACAME – Burkina Faso Galien Forum Africa Youth leadership training (part 1)
2021 Anne-Maryse K’Habore CAMEG General Manager of CAMEG – SG of ACAME – Burkina Faso Galien Forum Africa Youth leadership training
2021 William G. Kaelin Harvard Medical School & Dana-Farber Cancer Institute Sidney Farber Professor of Medicine, Galien Forum USA New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2021 Jeanne Kagame Rwanda 1st Lady of Rwanda Galien Forum Africa Closing ceremony
2020 Kenneth Kaitin Tufts Center for the Study of Drug Development, Tufts University School of Medicine Director Jerusalem Ethics Forum Societal, legal & ethical challenges around access to covid-19 vaccines
2010 Kenneth Kaitin Tufts Center for the Study of Drug Development Director Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2021 Amir Kalali CNS Summit; Decentralized Trials & Researched Alliance; Chief Currator & Chairman Galien Webinars Series Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2020 Amir Kalali CNS Summit; Decentralized Trials & Researched Alliance; Chief Currator & Chairman Galien Webinars Series Digital health in the aftermath of covid-19
2020 Milind Kamkolkar CELLARITY Chief Digital & Data Officer Galien Webinars Series The digital health enterprise: start-up trends & the culture of big pharma
2020 Eugene Kandel Start Up Nation Central Chief Executive Officer Galien Webinars Series Digital health in the aftermath of covid-19
2012 Eric Kandel Department of Neuroscience, Columbia University, New York Nobel Laureate, Professor & Fred Kavli Professor, Galien Forum USA Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2010 Eric Kandel Columbia University Nobel Laureate Professor Galien Forum USA Translational neuroscience: academic-industrial collaborations in cns diseases
2021 Barinder Kang Novartis Vice President & Head, US Oncology Medical (Radio lig& Therapy) Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021 Amadou Kanoute CICODEV NGO – Senegal President Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020 Salim Abdool Karim CAPRISA (South Africa) Director Galien Forum Africa Clinical trials in africa sub-theme 2:
2011 Brian Kaspar AveXis, Inc Scientific Founder & Chief Scientific Officer Galien Forum USA The promise of gene therapy
2022 Nobuko Kato Takeda Vice President, Global Head of External Communications, Corporate Communications & Public Affairs Galien Webinars Series Golden Jubilee - Best Orphan Rare Category
2022 Ariel Katz H1 Co-Founder & CEO Galien Forum USA Diversity and health equity in the future creation of medicine
2012 Russell Katz Division of Neurology Products, Center for Drug Evaluation & Research, Food & Drug Administration Director Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2020 Michael Kauffman Karyopharm Therapeutics Inc Chief Executive Officer Co-Founder Galien Week of innovation Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2022 Paramjit Kaur Servier Pharmaceuticals Asset Leader Galien Week of Innovation Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence
2022 Patrick J. Kennedy The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction & the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US Former U.S. Representative (D-RI); Founder Galien Forum USA Mental health in America, a public health crisis
2019 Patrick J. Kennedy The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction & the Opioid Crisis; Co-Founder, One Mind; Co-Chair, Mental Health for US Former U.S. Representative (D-RI); Founder Galien Forum USA The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2018 Admasu Kesete RBM end malaria Chief Executive Officer Galien Forum Africa Financing africa’s healthcare
2010 Mark Kessel Symphony Capital LLC Managing Director Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2021 Ibrahima Khalilou Dia e-health Dpt of Ministery of Health & Social Welfare – Senegal Coordinator Galien Forum Africa Innovations & ethic for global health security
2020 Ibrahima Khalilou Dia e-health Dpt of Ministery of Health & Social Welfare – Senegal MSAS digital health unit Galien Forum Africa What place for digital health & innovations? sub-theme 3:
2010 Kostas Kidos Oracle Corporation Pharmacovigilance in the Intersection of Healthcare & Life Sciences Vice President, Safety & PV Strategy Galien Forum USA The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2021 George Kimathi Capacity Building Institute, Amref Health Africa Director Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2022 Robert Kissling Bausch + Lomb VP Medical&Scientific Affairs Galien Week of Innovation Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2014 William E. Klitgaard Covance Senior Vice President et Information Director Galien Foum Monaco Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2021 Stephanie Klocke Becton, Dickinson & Company Vice President of Research & Development Galien Week of innovation How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2020 Stephanie Klocke Becton, Dickinson & Company Vice President of Research & Development Galien Week of innovation What is medtech innovation doing for patients with specialized needs for treatment?
2022 Volker Knappertz Aurinia Pharmaceuticals Inc. Executive VP R&D Galien Week of Innovation Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2012 Jean-Pierre A. Kocher The Bioinformatics Core (BIC) of the Mayo Clinic Head Galien Forum USA Addressing big datachallenges in genomics & personalized healthcare
2020 Robert Kowal Medtronic Chief Medical Officer, Vice President of Medical Affairs & Business Development Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2015 Adrian R. Krainer Cold Spring Harbor Laboratory, Watson School of Biological Sciences St. Giles Foundation Professor of Molecular Genetics, Program Chair, Cancer & Molecular Biology, Galien Forum USA Spinal muscular atrophy: charting the pathway to clinical progress
2022 Nikolaus Krall Exscientia VP, Precision Medicine Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Florian Krammer Icahn school of medicine at mount Sinai Pofessor of microbiology, pathology, molecular and cell based medicine, Galien Forum USA Covid pandemic science 2022: current vaccines and treatments and the future outlook
2022 Daniella Kranjac Dynamk Capital LLC Founding Partner Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2017 Jörg Kreuzer Boehringer Ingelheim Pharma GmbH & Co. KG Therapeutic Area Head Medicine CV Galien Forum USA Atrial fibrillation
2012 Health Sciences Global Business Unit Kridel Ferghana Partners Partner Galien Forum USA The changing face of chinese healthcare
2013 Mark Kris Memorial Sloan-Kettering Cancer Center Chair Chief, Thoracic Oncology Services, Galien Forum USA Oncology: newer therapies
2017 Jim Krueger Rockefeller University Laboratory for Investigative Dermatology, Galien Forum USA Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2018 Seema Kumar Johnson & Johnson Vice President Galien Forum Africa Plenary Panel - women in stem in africa
2021 Pradip Kumar Sasmal Dr. Reddy’s Laboratories Vice President & Head of CMC, Differentiated Products Galien Week of innovation What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2021 Angella Kyomugisha Women Innovators Incubator program Participant Galien Forum Africa Women & stem in the global health security context
2018 Paul Lalvani Empower School of Health, India Dean & Director Galien Forum Africa Universal access to essential & others medicines
2016 Story Landis National Institute of Neurological Disorders & Stroke, National Institutes of Health (NIH), NIH BRAIN Initiative Former Director, & Co-Founder Galien Forum USA Spinal muscular atrophy: charting the pathway to clinical progress
2022 Martin Landray Oxford University Professor of Medicine & Epidemiology Galien Forum UK Clinical trials & regulations: what have we learned from covid?
2021 Robert S. Langer David H. Koch Institute MIT Professor Galien Week of innovation What is med tech innovation doing for patients with specialized needs for treatment?
2020 Robert S. Langer David H. Koch Institute MIT Professor Galien Week of innovation What is medtech innovation doing for patients with specialized needs for treatment?
2018 Robert S. Langer Massachusetts Institute of Technology Professor Galien Forum USA Novel approaches to combatting opioid addiction
2015 Robert S. Langer Massachusetts Institute of Technology Professor Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2021 Peter Langmuir Incyte Group Vice President of Oncology Targeted Therapeutics Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2022 Jacob LaPorte Novartis Pharmaceuticals Corporation Co-Founder, Global Head Galien Week of Innovation Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2020 Margaret Lartey Ghana Dean of the Faculty of Medicine Galien Forum Africa Place of women in innovation related to covid 19 sub-theme 2:
2012 Martin Leach Broad Institute, MIT & Harvard Chief Information Officer, Galien Forum USA Addressing big datachallenges in genomics & personalized healthcare
2013 John Lechleiter Eli Lilly & Company Chairman & Chief Executive Officer Galien Forum USA Affordable care act us healthcare in transition: the stakes for industry
2022 Matthieu Leclerc-Chalvet Therapixel CEO Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021 Matthieu Leclerc-Chalvet Therapixel Chief Executive Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Melissa Lederer mHUB Chief Experience Officer Galien Week of Innovation Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2022 Myrto Lee BCG Managing Director & Partner Galien Forum UK Clinical trials & regulations: what have we learned from covid?
2022 Patrice A. Lee Pfizer Inc. VP Pharmaco Exploratory Devt Galien Week of Innovation Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2021 Philina Lee Blueprint Medicines Senior Vice President, Head of Portfolio Strategy Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2016 Jonathan S. Leff Deerfield Institute Partner, Deerfield Management; Chairman, Galien Forum USA Next generation antimicrobials – shaping policy to develop new business models
2013 Jeffrey Leiden Vertex Chairman, President & Chief Executive Officer Galien Forum USA Improving efficiency in drug development
2022 Arjen Lemmen Argenx VP, Corporate Devt & Strategy Galien Week of Innovation BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2020 David J. Lennon Novartis Gene Therapies President Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2016 John Leonard Intellia Therapeutics President and Chief Executive Officer Galien Forum USA Molecular scissors: what can we expect from gene editing?
2020 Jean Leonetti Sophia Antipolis Urban Community President Jerusalem Ethics Forum Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2015 Nick Leschly Bluebird President & Chief Executive Officer Galien Forum USA Delivering on the patient promise of gene therapy
2021 Steven J. Lester Mayo Clinic-ASU MedTech Accelerator & Professor of Medicine Chief Medical Officer Galien Week of innovation How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2020 Steven J. Lester Mayo Clinic-ASU MedTech Accelerator Chief Medical Officer Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2021 Franck Leveiller Alcon Senior Vice President, Head, Global Research & Development Galien Week of innovation What is med tech innovation doing for patients with specialized needs for treatment?
2022 Gail D. Lewis Genentech Senior Principal Scientist Galien Week of Innovation Laureates Media Presentation
2020 Tanya Lewis Scientific American Associate Editor for Health & Medicine Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2020 Dean Y Li Merck & Co., Inc. Senior Vice President - Discovery Sciences & Translational Medicine - Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2013 Richard Lifton Yale University School of Medicine Professor Galien Forum USA Personalized medicine: effect on drug r&d & patient care
2018 Dan R. Littman Vedanta Biosciences Co-Founder Galien Forum USA The gut microbiome: opportunities & challenges
2017 Dan R. Littman American Association of Immunology Former President Galien Forum USA Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2010 Rodolfo R. Lliná S New York University Chairman Department of Physiology & Neuroscience Galien Forum USA Translational neuroscience: academic-industrial collaborations in cns diseases
2014 Donald Lloyd-Jones Northwestern University in Chicago. Chairman of the Department of Preventive Medicine Galien Forum USA Heart attack guidelines
2011 Peter D. Loftus contributor to Wall Street Journal Dow Jones Newswires reporter covering pharmaceutical industry; Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2022 Sylvie Lombardi BD Director of R&D Galien Week of Innovation Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2012 Roger Longman Real Endpoints Chief Executive Officer Galien Forum USA Moderator
2011 Roger Longman Real Endpoints Chief Executive Officer Galien Forum USA What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2010 Roger Longman Real Endpoints Chief Executive Officer Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2022 Michelle Longmire Medable Chair of the Board - President & Chief Executive Officer Galien Forum USA Covid pandemic science 2022: current vaccines and treatments and the future outlook
2021 Michelle Longmire Medable Chair of the Board - President & Chief Executive Officer Galien Webinars Series The incubators of innovation: academic medical centers as digital health champions
2021 Michelle Longmire Medable Chair of the Board - President & Chief Executive Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Michelle Longmire Medable Co-founder & CEO, Moderator Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Carole Longson Medicines Discovery Catapult Vice Chair Galien Forum UK Access to innovation: optimizing health for patient populations
2012 William Looney Executive Magazine Editorial Director Pharmaceutical Galien Forum USA Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2013 Jan Lundberg Lilly Research Labs, Lilly & Co. Executive Vice President, Science & Technology & President Galien Forum USA Improving efficiency in drug development
2022 Lusong Luo BeiGene Senior VP, External Innovation Galien Week of Innovation Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2021 Crystal L. Mackall Ernest & Amelia Gallo Family, Stanford University Professor of Pediatrics & Internal Medicine Galien Forum USA New breakthroughs in the biology of cancer: pioneering novel ways to enhance & restore the body’s ability to fight cancer
2015 Charles R. Mackay Pfizer Inc. Inflammation & Immunology, Galien Forum USA Microbiota in human diseases
2016 Sandi Macrae Sangamo BioSciences President & Chief Executive Officer Galien Forum USA Molecular scissors: what can we expect from gene editing?
2021 Serigne Magueye Gueye Campus franco-senegalais – Senegal Director General Galien Forum Africa Conference on reform in health training
2021 Sadiqa Mahmood Health Catalyst General Manager & Senior Vice President Life Science Business Galien Webinars Series Data governance in a converging world: public & private sector approaches to the management of emerging health technologies.
2021 Aliou Maïga West & Central Africa of the International Finance Corporation IFC Regional Director Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020 Hilary Malone Valo Health Chief Operating Officer Galien Webinars Series Digital health improving research & care
2021 El Hadji Mamadou Ndiaye Prevention at the Ministry of Health & Social Action – Senegal Director Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020 Flavio Manetlli Dompe U.S. Inc. Chief Medical Officer Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2021 Carl  Manlan ECOBANK Foundation – International – Ivory Coast Director of Operations Galien Forum Africa Meeting of young innovators with investors
2020 Carl Manlan ECOBANK Foundation – International – Ivory Coast Director of Operations Galien Forum Africa Financing the response to covid 19
2020 John Maraganore Alnylam Chief Executive Officer Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2022 Joel S. Marcus Alexandria real estate equities, inc./Alexandria venture investments Executive Chairman & Founder Co-Founder, Galien Forum USA Mental health in America, a public health crisis
2021 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit Chairman, Chief Executive Officer & Founder, Co-Founder Galien Forum USA Combating the opioid crisis in america
2020 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit Chairman, Chief Executive Officer & Founder, Co-Founder Galien Forum USA Covid-19 vaccines: the path to the holy grail
2019 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Executive Chairman & Founder Co-Founder, Galien Forum USA Can disruptive innovation positively impact healthcare costs?
2018 Joel S. Marcus Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Alexandria Summit Executive Chairman & Founder Co-Founder, Galien Forum USA Cancer in a time of disruption
2017 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Co-Moderator, Chairman, Chief Executive Officer & Founder, Co-Founder Galien Forum USA Addressing unmet medical needs with early-stage life science venture capital
2014 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit Chairman, Chief Executive Officer & Founder, Co-Founder Galien Forum USA The future of digital health
2013 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Chairman Galien Forum USA Welcome & intro
2012 Joel S. Marcus Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Alexandria Summit Chairman, Chief Executive Officer & Founder, Co-Founder Galien Forum USA Welcome Remarks
2021 Yuri Maricich Pear Therapeutics Chief Medical Officer & Head of Development Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2020 Yuri Maricich Pear Therapeutics Chief Medical Officer & Head of Development Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2016 Michael Mark Research Boehringer Ingelheim Pharma GmbH & Co. KG Research Vice President & Global Head of Cardio Metabolic Diseases Galien Forum USA Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2021 Wanda Markotter Centre for Viral Zoonoses Pretoria – South Africa Director Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 2
2018 Peter Marks Center for Biologics Evaluation & Research, FDA Director Galien Forum USA The promise of gene therapy
2014 Peter Marks Center for Biologics Evaluation & Research, FDA Director Galien Forum USA Fireside chat | delivering on the patient promise of gene therapy
2012 Lynn Marks Clinical Platforms & Sciences, GlaxoSmithKline plc Senior Vice President, Projects Galien Forum USA Infectious diseases: a global healthcare challenge
2022 Peter Marks Center for Biologics Evaluation & Research, FDA Director Galien Forum USA Covid pandemic science 2022: current vaccines and treatments and the future outlook
2022 John Martin Butterfly Network Inc Chief Medical Officer Galien Week of Innovation Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2018 Kelsey C. Martin Simons Foundation Autism Research Initiative (SFARI) Director Galien Forum USA Cancer in a time of disruption
2010 Sharon Mates Intra-Cellular Therapies Chairman & Chief Executive Officer Galien Forum USA Translational neuroscience: academic-industrial collaborations in cns diseases
2021 Eric Mayes Endomagnetics Ltd. Chief Executive Officer Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2020 Eric Mayes Endomag Ltd. Chief Executive Officer Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2015 Sarkis K. Mazmanian California Institute of Technology Louis & Nelly Soux Professor of Microbiology Galien Forum USA The gut microbiome: opportunities & challenges
2015 Sarkis K. Mazmanian California Institute of Technology Louis & Nelly Soux Professor of Microbiology Galien Forum USA Microbiota in human diseases
2020 Aminata Mbengue Ndiaye Territorial Communities HCCT (Senegal) President High Council Galien Forum Africa Africa post covid 19
2021 Souleymane Mboup IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) Executive Director Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2021 Souleymane  Mboup IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) Co-President Galien Forum Africa Closing ceremony
2020 Souleymane Mboup IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) President & Chief Executive Officer Galien Forum Africa Research facing covid 19
2018 Souleymane Mboup IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) Chief Executive Officer Galien Forum Africa Remarkable women engage for humanity
2018 Souleymane Mboup IRESSEF (Institute for Health Research, Epidemiological Surveillance & Training) Chief Executive Officer Galien Forum Africa managing infectious diseases & pandemics
2021 Cheikh Mbow Future Africa University of Pretoria – South Africa Director Galien Forum Africa Youth leadership training (part 1)
2021 Cheikh Mbow Future Africa University of Pretoria – South Africa Director Galien Forum Africa Youth leadership training
2020 Cheikh Mbow Future Africa University of Pretoria (South Africa) Inaugural Director Galien Forum Africa Environmental impact of the covid 19 pandemic sub-theme 4:
2018 Cheikh Mbow Harvard Chief Executive Officer Galien Forum Africa The health consequences of climate change
2018 Corey McCann Pear Therapeutics President & Chief Executive Officer Galien Forum USA Novel approaches to combatting opioid addiction
2022 Chrissa McFarlane Patientory Inc CEO Galien Week of Innovation Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2021 Chrissa McFarlane Patientory Inc. Founder & Chief Executive Officer Galien Week of innovation Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2016 Mark McLellan Professor of Business, Medicine, & Health Policy, Duke-Robert J. Margolis Center for Health Policy & Robert J. Margolis, Duke University Director Galien Forum USA Next generation antimicrobials – shaping policy to develop new business models
2014 Mark McLellan the Brookings Institution Senior Fellow & Director of the Health Care Innovation & Value Initiative Galien Forum USA Us health reform
2021 Sapna McManus Genentech Head of Patient Inclusion & Health Equity, Chief Diversity Office Jerusalem Ethics Forum Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2015 Michelle McMurry-Heath BIO President & Chief Executive Officer Galien Forum USA What’s holding back the technology revolution in clinical trials?
2018 Nicolas Meda Burkina Faso Minister ofHealth Galien Forum Africa managing infectious diseases & pandemics
2018 Nicolas Meda Burkina Faso Minister of Health Galien Forum Africa Remarkable women engage for humanity
2022 Gerold Meinhardt Daiichi Sankyo Vice President, Asset & Portfolio Management Galien Week of Innovation Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2015 Ira Mellman Genentech Vice President, Research Oncology, Galien Forum USA What’s holding back the technology revolution in clinical trials?
2022 Johanna Mercier Gilead Sciences Chief Communications Officer Galien Webinars Series Golden Jubilee - Best Orphan Rare Category
2020 Jane Metcalfe Neo.Life. Wired Magazine Chief Executive Officer Co-Founder Galien Webinars Series Digital health in the aftermath of covid-19
2022 Philippe Michel FUTURE4CARE COO Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020 Jennifer  Miller Yale School of Medicine Assistant Professor Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2011 Steve Miller Express Scripts Senior Vice President & Chief Medical Officer Galien Forum USA Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2019 Talya Miron-Shatz Israel Decision Scientist Jerusalem Ethics Forum Human reproduction: technical limit, ethical limit
2021 Kenneth I. Moch Center for Global Health Innovation & Global Health Crisis Coordination Center Senior Advisor to the Chairman Jerusalem Ethics Forum Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2020 Kenneth I. Moch Center for Global Health Innovation & Global Health Crisis Coordination Center Senior Advisor to the Chairman Jerusalem Ethics Forum Societal, legal & ethical challenges around access to covid-19 vaccines
2021 Serigne Modou Babou Cauris technologiesUniversité Cheikh Anta Diop de Dakar Professor Galien Forum Africa Conference on reform in health training
2022 Alexandra Moens H1 Dir Product Marketing - Moderator Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Alexandra Moens H1 Dir Product Marketing - Moderator Galien Week of Innovation Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2022 Alexandra Moens H1 Dir Product Marketing Moderator Galien Week of Innovation BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021 Matshidiso Moeti WHO Regional Office for Africa Regional Director Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 3
2021 Matshidiso Moeti WHO Regional Office for Africa Regional Director Galien Forum Africa Closing ceremony
2020 Matshidiso Moeti WHO Regional Office for Africa Regional Director Galien Forum Africa The response of african countries to the covid-19 pandemic
2020 Matshidiso Moeti WHO Regional Office for Africa Regional Director Galien Forum Africa Africa post covid 19
2018 Matshidiso Moeti WHO Regional Office for Africa Regional Director Galien Forum Africa Which plan for non communicable diseases?
2021 Mark Mogul Servier Pharmaceuticals Head of Medical Affairs Galien Week of innovation Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2020 Briggs Morrison Syndax Chief Executive Officer Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2020 Ponda Motsepe – Ditshego Amgen Bone Executive Medical Director Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2018 Aaron Motsoaledi South Africa Minister of Health Galien Forum Africa Financing africa’s healthcare
2020 Vanessa Moungar African Development Bank (Chad) Director of Gender & Civil Society Galien Forum Africa Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2022 Katherine Moyer Skipta VP Content & Com - Moderator Galien Week of Innovation Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2022 Shephard Mpofu Novartis Gene Therapies SVP, CMO Galien Week of Innovation BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021 Shephard Mpofu Novartis Senior Vice President & Chief Medical Officer Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2021 Arnold Munnich Hopital Necker Enfants Malades Chief of Dpeartment Galien Webinars Series The impact of digital technology in clinical trials: ethical considerations (french edition)
2020 Arnold Munnich University Paris-Descartes, France Genetics Jerusalem Ethics Forum Science, intelligence, ethics: a multi-faceted response to the challenges of covid-19
2019 Arnold  Munnich University Paris-Descartes, France Genetics Jerusalem Ethics Forum Personalized genomics medicine: the value of knowing
2019 Arnold  Munnich University Paris-Descartes, France Genetics Jerusalem Ethics Forum 2020/2030 agenda “facing the next ethical challenges”
2021 Terry Murphy Janssen COVID-19 Clinical Dev. Relaunch Leader Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-21
2016 John Mc Murray Institute of Cardiovascular & Medical Sciences, University of Glasgow Professor of Medical Cardiology, Galien Forum USA Keynote
2015 John Mc Murray Institute of Cardiovascular & Medical Sciences, University of Glasgow Professor of Medical Cardiology, Galien Forum USA Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2019 Mordechai Muszkat Hadassah University Hospital at Mt Scopus, Israel Head of the Department of Medicine Jerusalem Ethics Forum Health policy & financing innovation: ethical considerations, cost & the role of the patient
2021 John Mwangi Daktari Media Chief Executive Officer Galien Forum Africa Leadership & innovation, meet the winners of the africa young innovators award for health
2021 Whitney Mwangui African Union Advocacy, Partnership & Communication Specialist Galien Forum Africa Leadership & innovation, meet the winners of the africa young innovators award for health
2015 Elizabeth Nabel Brigham & Women’s Hospital President Galien Forum USA What’s holding back the technology revolution in clinical trials?
2021 Mame Nahe Diouf Institute of Agricultural Research (ISRA), National Laboratory of Livestock & Veterinary Research (LNERV) – Senegal Director Galien Forum Africa Involvement of women researchers in the mhw
2015 Gerard Nahum Bayer Pharmaceuticals Vice President, Global Clinical Development for Medical Devices & eHealth, Galien Forum USA What’s holding back the technology revolution in clinical trials?
2021 Nuriat Nambogo Women Innovators Incubator program Participant Galien Forum Africa Women & stem in the global health security context
2014 Tara Narula CBS This Morning Medical Contributor, Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2015 Ameet Nathwani Novartis Senior Vice President & Global Head of Medical Affairs. Galien Forum USA Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2018 Sidy Ndao University of Nebraska-Lincoln - USA Associate Professor, Galien Forum Africa Plenary Panel - women in stem in africa
2021 Massamba Ndiaye Ubuntu University, National Digital Debate of the Youth Founder Executive Chairman Galien Forum Africa Youth leadership training (part 1)
2021 Massamba Ndiaye Ubuntu University, National Digital Debate of the Youth Founder Executive Chairman Galien Forum Africa Youth leadership training
2020 Youssou Ndiaye MSAS- Senegal Director of Planning, Research & Statistics Galien Forum Africa Health & socio-economic impact of the covid 19 pandemic in africa sub-theme 1: resilience of health systems & continuity of care: state of play, challenges & rerspectives
2018 Alioune Ndiaye UN Special Advisor Galien Forum Africa The health consequences of climate change
2021 Aïta Ndir Dia WERGU – Senegal Co-founder Galien Forum Africa Meeting of young innovators with investors
2021 Babacar Ndoye WHO Expert-Consultant Senegal Expert-Consultant Galien Forum Africa « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2018 Lee N. Newcomer UnitedHealthcare Principal, Lee Newcomer Consulting LLC, Former Senior Vice President, Oncology & Genetics, Galien Forum USA Cancer in a time of disruption
2014 William Newsome Stanford University of Medicine Ph.D. Harman Family Provostial Professor & Professor of Neurobiology, Galien Forum USA The brain initiative
2021 Sobel Ngom Consortium Jeunesse Senegal Executive Director Galien Forum Africa Meeting of young innovators with investors
2020 Sobel Ngom Social change Factory Executive Director Galien Forum Africa Youth forum: leadership & young people facing covid-19
2018 Mabingue Ngom WCARO (Western & Central Africa Region), UNFPA Regional Director Galien Forum Africa Universal access to essential & others medicines
2020 Marie Khemesse Ngom Ndiaye National Committee for the Management of Epidemics (Senegal) Director General of Health & President Galien Forum Africa Professional women & covid 19 sub-theme 3: contribution of professional women in the response against covid 19: state of play, challenges & perspectives
2021 Catherine Nguila Winner of the L’Oreal /Unesco Africa Prize for Women in Science – Kenya Winner of the L’Oreal /Unesco Africa Prize Galien Forum Africa Involvement of women researchers in the mhw
2018 Mary Teuw Niane Research & Innovation, Senegal Minister of Higher Education Galien Forum Africa Plenary Panel - women in stem in africa
2020 Cheikh Ibrahima Niang FST Socio-anthropologis Galien Forum Africa Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4:
2011 Steven Nissen Clevel& Clinic Lerner School of Medicine at Case Western Reserve U Chairman, Department of Cardiovascular Medicine Clevel& Clinic Foundation & Professor of Medicine, Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2022 Wilfred Njagi Villgro Africa CEO Galien Week of Innovation Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2021 John Nkengasong African Centers for Disease Control & Prevention (CDC Africa) President the Prix Galien Africa Jury International – Cameroon Director Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 4
2021 John Nkengasong African Centers for Disease Control & Prevention (CDC Africa) President the Prix Galien Africa Jury International – Cameroon Director Galien Forum Africa Closing ceremony
2021 John  Nkengasong Prix Galien Africa Jury International – Cameroon CDC Africa Director Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020 John Nkengasong African Centers for Disease Control & Prevention (Africa CDC) Director Galien Forum Africa The response of african countries to the covid-19 pandemic
2020 John Nkengasong African Centers for Disease Control & Prevention (Africa CDC) Director Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2018 John Nkengasong CDC, Centre for Disease Control & Prenvention, Africa Director Galien Forum Africa Remarkable women engage for humanity
2018 John Nkengasong Centre for Disease Control & Prenvention - Africa Director Galien Forum Africa managing infectious diseases & pandemics
2011 Larry Norton Memorial Sloan-Kettering Cancer Center Deputy physician-in chief for breast cancer programs & medical director, Evelyn H. Lauder Breast Center, Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2020 Ngoy Nsenga COVID 19 & Program Manager for Emergency Response at WHO AFRO Incident Manager Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2021 Francine  Ntoumi Congolese Foundation for Medical Research (DR Congo) President & Executive Director Galien Forum Africa Involvement of women researchers in the mhw
2021 Mwelecele Ntuli Malecela Deportment of Control of Neglected Tropical Diseases World Health Organization Director Jerusalem Ethics Forum Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2015 Stephen Oesterle Medtronic, plc Senior Vice President Medicine & Technology Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2019 Joshua J. Ofman GRAIL, Inc Chief of Corporate Strategy & External Affairs Galien Forum USA Digital health -orchestrating patient- centricity from molecule to market
2021 Stephen Ogweno Stowelink Inc. – Kenya Young Innovators Galien Forum Africa Meeting of young innovators with investors
2021 Franz Okey Speak Up Africa Country Coordinator in Benin – Benin Country Coordinator Galien Forum Africa The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2021 Ngozi  Okonjo-Iweala World Trade Organization WTO – International – Nigeria Director General Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2011 Bernat Olle Vedanta Biosciences Chief Executive Officer Galien Forum USA The gut microbiome: opportunities & challenges
2021 Olayinka Olusola Omigbodun Representative of the Deans of ECOWAS-Nigeria Provost University of Ibadan, Representative of the Deans of ECOWAS Galien Forum Africa Youth leadership training (part 1)
2021 Olayinka Olusola Omigbodun Representative of the Deans of ECOWAS-Nigeria Provost University of Ibadan, Representative of the Deans of ECOWAS Galien Forum Africa Youth leadership training
2020 Olayinka Olusola Omigbodun University of Ibadan (Nigeria) Dean of the College of Medicine Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2020 Francis Omaswa African Center for Global Health & Social Transformation; 2019 NOGUCHI Prize Laureate (Ug& a) Executive Director Galien Forum Africa Multisectoral & community participation: strengths, weaknesses & recommendations sub-theme 4:
2020 Jorge Ortiz Bayer Global Medical Affairs Head Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2021 Anu Osinusi Gilead Sciences Vice President, Clinical Research for Hepatitis, Respiratory & Emerging Viruses Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2021 Cheikh  Oumar Seydi Bill & Melinda Gates Foundation Africa Scientific Advisory Committee Galien Forum Africa Innovations & ethic for global health security
2022 Jackie Pacelli AbbVie VP, Communications Galien Webinars Series Golden Jubilee - Best BioTech Category
2012 Michel Pairet Boehringer Ingelheim Member, Board of Managing Directors - Innovation, Galien Forum USA Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020 Alexandra Palt L’Oreal FoundationFrance President Galien Forum Africa Place of women in innovation related to covid 19 sub-theme 2:
2022 Susan Pandya Servier Pharmaceuticals Clin. Devt Head of Cancer Galien Week of Innovation Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2022 Menelas (Mene) Pangalos AstraZeneca Executive Vice President & President BioPharmaceuticals R&D Galien Forum UK Clinical trials & regulations: what have we learned from covid?
2014 Ed Park Athenahealth, Inc Executive Vice President & Chief Operating Officer Galien Forum USA The future of digital health
2012 Roy Parker University of Colorado, Boulder Professor Cech-Leinwand Endowed Chair of Biochemistry Galien Forum USA Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020 Amanda Paschke Merck & Co., Inc. Executive Director Global Clinical Development Galien Week of innovation Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2011 Richard C. Pasternak Merck & Co., Inc Former Vice-President & Past Director Galien Forum USA What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021 Muhammad Ali   Pate Harvard University Former Minister of Health (Nigeria/ USA) Public Health Leadership Galien Forum Africa Women’s leadership in global health security
2020 Muhammad Pate World Bank Public Health Leadership Galien Forum Africa Financing the response to covid 19
2022 Kiran Patel Janssen VP Clinical Devt, Solid Tumor Galien Week of Innovation Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2015 Steven Paul Voyager Therapeutics President & Chief Executive Officer Galien Forum USA Untangling the web of neurodegeneration: how far & how soon?
2021 Eric M Pearlman Eli Lilly & Company Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs Galien Week of innovation What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2020 Eric M Pearlman Eli Lilly & Company Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2020 Eric M Pearlman Eli Lilly & Company Senior Medical Director-Migraine/Pain, Neuroscience Medical Affairs Galien Week of innovation The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2011 Steve Pearson Institute for Clinical & Economic Review (ICER) Founder & President Galien Forum USA Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2019 Renzo Pegoraro Lanza Foundation, Vatican Scientific Director Jerusalem Ethics Forum Human reproduction: technical limit, ethical limit
2021 Louis Penali Life Sciences Ethics Committee, Cote d’Ivoire, MSF Scientific Advisor (West & Central Africa) International – Côte d’Ivoire President Galien Forum Africa Innovations & ethic for global health security
2022 Rodolfo Perini Merck & Co., Inc AVP Global Clinical Dvt Onco Galien Week of Innovation Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2021 Greg  Perry IFPMA Assistant Director-General Galien Forum Africa Women & stem in the global health security context
2011 Magnus Persson The Column Group Managing Partner Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2012 Jennifer C. Petter Arrakis Founder & Chief Scientific Officer Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2010 Seth Pinsky New York City Economic Development Corporation (NYCEDC) President Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2011 Gary Pisano Harvard Business School Harry E. Figgie Professor of Business Administration, Galien Forum USA Making medicines affordable
2011 Peter J. Pitts Center for Medicine in the Public Interest President  Galien Forum USA What is "value" & how can it be measured & demonstrated in therapeutic innovations? breaking down the barriers of the past
2021 David Platt Novartis Pharmaceuticals Corporation Vice President, Medical Unit Head Cardiovascular, Renal & Metabolism Medical Unit Galien Week of innovation What can patients with chronic conditions expect from medicines advances within the next five to ten years? how is chronic disease research moving from incremental & maintenance therapies to real breakthroughs toward cure & prevention?
2020 David Platt Novartis Pharmaceuticals Corporation Vice President, Medical Unit Head Cardiovascular, Renal & Metabolism Medical Unit Galien Week of innovation The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2012 Andy Plump Takeda Pharmaceuticals Company Ltd President, Research & Development, Galien Forum USA Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2022 Theresa Podrebarac Horizon Therapeutics SVP Clinical Devt Galien Week of Innovation Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2018 Marie-Pierre Poirier WCA (Western & Central Africa) UNICEF Regional Director Galien Forum Africa Addressing chronic malnutrition
2022 Catherine Pollard Centre for Improving Data Collaboration, NHSX Director Galien Forum UK Digital health innovation: a key driver of next generation healthcare – what & when?
2012 Richard F. Pops Alkermes Chairman & Chief Executive Officer Galien Forum USA Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2012 William Potter National Institute of Mental Health Senior Advisor, Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2013 John Thomas Potts, Jr Massachusetts General Hospital & Harvard Medical School Distinguished Jackson Professor of Clinical Medicine, Galien Forum USA The promise of gene therapy
2022 Bernard Poussot Roche holding & Wyeth Director & Former Chairman & CEO Galien Forum USA - Chair prix Galien awards ceremony categories: > best startup > best digital health solution > inaugural best incubator/accelerator/equity
2020 Santosh Prabhu Abbott Structural Heart Divisional Vice President, Product Development Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2021 Lisa Prasad Henry Ford Health System Vice President & Chief Innovation Officer Galien Webinars Series The incubators of innovation: academic medical centers as digital health champions
2022 David Prior NHS England Lord. Galien Forum UK Access to innovation: optimizing health for patient populations
2012 Stanley Prusiner University of California, San Francisco (UCSF) Nobel Laureate, Professor of Neurology & Biochemistry, Galien Forum USA Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020 Dee Punungwe Kenya researcher Galien Forum Africa Place of women in innovation related to covid 19 sub-theme 2:
2010 Dennis Purcell Aisling Capital Senior Managing Director Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2011 Mark Pykett Neoprobe Corporation President & Chief Executive Officer Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2011 Paul I. Rachlin Proskauer Partner Galien Forum USA Funding innovation new trends in the healthcare m&a l& scape
2020 Angela Radcliffe CAPGEMINI INVENT R&D Practice Lead,m Founding Member, CoS, IEEE Global Initiative to Standardize Fairness in the Trade of Data; Advisory Board Member to Startups in Life Science; Clinical Research Advocate Galien Webinars Series The digital health enterprise: start-up trends & the culture of big pharma
2014 Daniel Rader the University of Pennsylvania Medicine Galien Forum USA Heart attack guidelines
2020 Sri Radhakrishnan Pulmonx Corporation Chief Technical Officer Galien Week of innovation What is medtech innovation doing for patients with specialized needs for treatment?
2022 Maha Radhakrishnan Biogen Group senior vice president & chief medical officer Galien Forum USA Diversity and health equity in the future creation of medicine
2021 Charlemagne Marie Ragnag-Newende Ouedraogo Burkina Faso Minister of Health Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 5
2022 June Raine MHRA Chief Executive Officer Galien Forum UK Clinical trials & regulations: what have we learned from covid?
2020 Jean-Daniel Rainhorn Geneva University/IHEID, Switzerland Honorary Professor in International Health & Humanitarian Action Jerusalem Ethics Forum Up-to-date reflection on society, medicine & reproduction
2019 Jean-Daniel Rainhorn Geneva University/IHEID, Switzerland Honorary Professor in International Health & Humanitarian Action Jerusalem Ethics Forum Health policy & financing innovation: ethical considerations, cost & the role of the patient
2022 Reshma Rangwala Karyopharm Therapeutics Inc. CMO Galien Week of Innovation Hematologic Cancers and Gene-based “Tumor Agnostic” Therapies How much more mileage is in store for blood-based cancer survival rates, which have been increasing steadily in recent years? And what is being done about the flip side of this success, expressed in more treatment-related morbidities, disease relapse and higher incidence
2020 Ishu Rao Impulse Dynamics Medical Director Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2022 Simon Rasalingham behold.ai CEO and Chairman Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2012 Guido Rasi European Medicines Agency Executive Director Galien Forum USA Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2012 Guido Rasi European Medicines Agency Executive Director Galien Forum USA 21st century science: building partnerships, managing for success
2020 Mads Frederik Rasmussen Novo Nordisk A/S Corporate Project Vice President for GLP-1, CV & Outcomes Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2019 Franklin Rausky Elie Wiesel Institute, France Director of Jewish Studies Jerusalem Ethics Forum Life sciences: psychiatry, humanism & totalitarianism
2022 Lynn Ray Olympus America Inc. VP, GM, Global Respiratory Olympus Galien Week of Innovation Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2017 Vivek Reddy Icahn School of Medicine, Mount Sinai Leona M. & Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Galien Forum USA Atrial fibrillation
2022 Andy Richards Congenica Ltd, Owlstone Medical, Closed Loop Medicine & ieso Digital Health CBE I Chair Galien Forum UK Digital health innovation: a key driver of next generation healthcare – what & when?
2021 Valery Ridde IRD,Montreal-Canada Teacher Galien Forum Africa « one health » & « global health » approaches: are they complementaries or contradictories in the global health security context?
2015 Robert H. Ring Autism Speaks Chief Executive Officer Galien Forum USA Autism - the next decade
2021 Michael Ringel BCG Managing Director & Senior Partner Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2020 Michael Ringel BCG Managing Director & Senior Partner Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2011 Michael Ringel BCG Managing Director & Senior Partner Galien Forum USA Drugging the undruggable» with novel approaches to small molecule design
2022 Michael Ringel BCG Managing Dir Sr Partner - Moderator Galien Week of Innovation Biotech - Cancer Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to treatment, particularly in solid tumors?
2021 Maryanne Rizk Medable Chief Strategy Officer Galien Forum USA The future is decentralized -- how the paradigm has changed & what it means for modern trials
2020 Maryanne Rizk IQVIA Senior Vice President, R&D Digital Strategy Galien Week of innovation Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2019 Maryanne Rizk IQVIA Senior Vice President, R&D Digital Strategy Galien Forum USA Digital health -orchestrating patient- centricity from molecule to market
2016 Maryanne Rizk Oracle Health Sciences Senior Vice President, R&D Digital Strategy Galien Forum USA Molecular scissors: what can we expect from gene editing?
2015 Maryanne Rizk Oracle Health Sciences Senior Vice President, R&D Digital Strategy Galien Forum USA Autism - the next decade
2022 Samantha Roberts NICE Chief Executive Officer Galien Forum UK Access to innovation: optimizing health for patient populations
2021 Antoine Rodrigue MODJAW Chief Executive Officer Galien Week of innovation In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2022 Sandy Rodriguez Roche Vice President, Communications Galien Webinars Series Golden Jubilee - Best BioTech Category
2011 Kent Rogers UnitedHealth Group Inc M.B.A., Senior Vice President, Industry Relations, Galien Forum USA Making medicines affordable
2011 Dana Rollison Moffitt Cancer Center Vice President, Total Cancer Care & Chief Health Information Officer, Galien Forum USA The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2013 Maria Grazia Roncarolo Stanford University Professor of Pediatrics & Medicine, Galien Forum USA Fireside chat | delivering on the patient promise of gene therapy
2019 Steve Rosenberg Oracle Health Sciences Senior Vice President & General Manager Galien Forum USA What’s holding back the technology revolution in clinical trials?
2013 Steve Rosenberg Oracle Health Sciences Senior Vice President & General Manager, Galien Forum USA The marriage of technology & medicine: bringing out the best in each other
2022 Michael Rosenblatt Galien Forum & flagship pioneering Co-Chair & Senior Partner Galien Forum USA Welcome
2022 Michael Rosenblatt Galien Foundation Committee Chair Galien Week of Innovation Laureates Media Presentation
2021 Michael Rosenblatt Flagship Pioneering Senior Partner Galien Week of innovation Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions?
2021 Michael Rosenblatt Flagship Pioneering Galien Forum Co-Chair Senior Partner Galien Forum USA Welcome
2020 Michael Rosenblatt Flagship Pioneering Chief Medical Officer, Co-Chair: Galien Forum Galien Forum USA The promise of gene therapy
2020 Michael Rosenblatt Flagship Pioneering Chief Medical Officer Galien Forum USA The next 50 years of innovation: where will it come from & how do we secure it?
2020 Michael Rosenblatt Flagship Pioneering Chief Medical Officer Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2020 Michael Rosenblatt Flagship Pioneering Chief Medical Officer Galien Forum USA Making medicines affordable
2013 Michael Rosenblatt Merck & Co., Inc. Executive Vice President & Chief Medical Officer Galien Forum USA The promise of gene therapy
2012 Michael Rosenblatt Merck & Co., Inc. Executive Vice President & Chief Medical Officer Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2011 Michael Rosenblatt Merck & Co., Inc. Executive Vice President & Chief Medical Officer Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2020 Kate Rosenbluth Cala Health Founding Chief Executive Officer & Chief Scientific Officer Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2019 Michal Rosen-Zvi IBM, Israel Director of Health Informatics Jerusalem Ethics Forum “artificial intelligence & ethics”
2014 Hans Rosling Karolinska Institutet, Sweden Global Health Galien Forum USA A new agenda for global health
2020 Joseph Ross Yale School of Medicine Medicine & Public Health Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2021 Scott T. Rottinghaus Alexion Pharmaceuticals Vice President, Head of Clinical Development, Hematology & Nephrology Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2015 John W. Rowe the Columbia University Mailman School of Public Health Julius B. Richmond Professor of Health Policy & Aging Galien Forum USA Us health reform: partnering, pricing & politics
2011 Francesco Rubino Metabolic & Diabetes Surgery Center, Weill Cornell Medical College Associate Professor of Surgery, Director, Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2020 Marcella Ruddy Regeneron Vice President, Strategic Program Direction, Immunology & Inflammation Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2021 Rodrigo Ruiz Soto Deciphera Senior Vice President, Clinical Development & Translational Medicine Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021 Renee Ryan Cala Health Chief Executive Officer Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2022 Renee Ryan, Cala Health CEO Galien Week of Innovation Laureates Media Presentation
2017 Lars Ryden Karolinska Institute, Stockholm, Sweden Senior Professor of Cardiology Galien Forum USA Atrial fibrillation
2016 Lars Ryden Karolinska Institute, Stockholm, Sweden Senior Professor of Cardiology Galien Forum USA Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2015 Lars Ryden Karolinska Institutet, Stockholm, Sweden Senior Professor of Cardiology Galien Forum USA Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2016 Michel Sadelain Center for Cell Engineering, Memorial Sloan Kettering Cancer Center Director Galien Forum USA Precision medicine: delivering on the promise
2021 Jim Sailer Population Council Executive Director, Center for Biomedical Research Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2020 Abdou Salam Fall Economic & Social Transformations (LARTES) (Senegal) Director of the Research Laboratory Galien Forum Africa Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2019 Ayman  Salem USA Neurosurgeon Jerusalem Ethics Forum “artificial intelligence & ethics”
2021 Papa Salif Sow Africa Health Department, Mastercard Foundation Director Galien Forum Africa Meeting of young innovators with investors
2020 Ndeye Salimata Diop Dieng Family, Gender & Child Protection (Senegal) Minister of Women Galien Forum Africa Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2021 Macky Sall Republic of Senegal President  Galien Forum Africa Inaugural Panel
2021 Amadou Alpha Sall Pasteur Institute - Dakar Director Galien Forum Africa Innovations & ethic for global health security
2020 Galaye Sall Country Coordinating Mechanism of the CCM Global Fund (Senegal) President Galien Forum Africa Financing the response to covid 19
2020 Amadou Alpha Sall Pasteur Institute - Dakar Director Galien Forum Africa Screening strategies for a person suspected of covid 19: state of play, strengths, points for improvement & recommendations. sub-theme 2:
2018 Amadou Alpha Sall Pasteur Institute - Dakar Director Galien Forum Africa Remarkable women engage for humanity
2018 Amadou Alpha Sall Pasteur Institute - Dakar Director Galien Forum Africa managing infectious diseases & pandemics
2019 Bengt Samuelsson Former President, Karolinska Institute; Former Chairman, Nobel Foundation Nobel Laureate; Galien Forum USA The marriage of technology & medicine: bringing out the best in each other
2017 Bengt Samuelsson Karolinska institute & Former chairman of the Nobel Foundation Nobel Laureate, Former President Galien Forum USA Atrial fibrillation
2016 Bengt Samuelsson Karolinska Institute & Former chairman of the Nobel Foundation Nobel Laureate, Former President Galien Forum USA Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2015 Bengt Samuelsson Karolinska Institute & Former Chairman of the Nobel Foundation. Stockholm, Sweden Nobel Laureate, Former President Galien Forum USA Confronting the crisis of heart failure: innovation in pharmacology & medical devices
2014 Bengt Samuelsson Karolinska institute & Former chairman of the Nobel Foundation Nobel Laureate, Former President Galien Forum USA A new agenda for global health
2011 Bengt Samuelsson Karolinska institute & Former chairman of the Nobel Foundation Nobel Laureate, Former President Galien Forum USA How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2010 Bengt Samuelsson Karolinska institute & Former chairman of the Nobel Foundation Nobel Laureate, Former President Galien Forum USA The changing l& scape of pharmacovigilance: the impact on medical innovation & human health
2019 Alfred Sandrock Biogen Executive Vice-President & Chief Medical Officer Galien Forum USA Spinal muscular atrophy: charting the pathway to clinical progress
2020 Rokia Sanogo National Institute of Public Health of Mali, WHO Head of the traditional medicine & Vice-president of the Advisory Committee on Traditional Medicine Galien Forum Africa Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5:
2015 Luca Santarelli Roche Pharma Research & Early Development, Roche Former Senior Vice President, Head of Neuroscience, Ophthalmology & Rare Diseases (NORD), Galien Forum USA Autism - the next decade
2021 Oulimata Sarr (West & Central Africa) International – Senegal UN Women Dakar Regional Director Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2020 Oulimata Sarr UN Women Regional Director Galien Forum Africa Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2020 Fatou Sarr Sow Gender Laboratory (Senegal) Director Galien Forum Africa Gender & innovations facing covid 19 sub-theme 1: gender & response to covid 19.
2012 Nadeem Sarwar Pfizer Senior Director - Head, Population Research & Head,Cardiovascular Genetics, Galien Forum USA Addressing big datachallenges in genomics & personalized healthcare
2020 George Scangos Vir Biotechnology Chief Executive Officer Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2014 George A. Scangos Biogen Idec Chief Executive Officer Galien Forum USA Us health reform
2022 Tom Schall ChemoCentryx President, CEO, Director Galien Week of Innovation BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2021 Adam Schayowitz Pfizer Oncology Medicine Team Group Lead (Breast Cancer, Colorectal Cancer & Melanoma) Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2019 David Schenkein Agios Pharmaceuticals General Partner, GV; Executive Chairman of the Board & Former Chief Executive Officer, Galien Forum USA Can disruptive innovation positively impact healthcare costs?
2018 David Schenkein Agios Pharmaceuticals Chief Executive Officer Galien Forum USA Cancer in a time of disruption
2019 Leonard S. Schleifer Regeneron Pharmaceuticals Founder, President & Chief Executive Officer, Galien Forum USA Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2013 Leonard S. Schleifer Regeneron Founder, President & Chief Executive Officer, Galien Forum USA Affordable care act us healthcare in transition: the stakes for industry
2020 Douglas Schlichting Eli Lilly & Company Development Director Immunology Product Development – baricitinib rheumatoid arthritis & COVID-19 Galien Week of innovation The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2014 Corinne Schmitz Blue-Reg pharma Consult President Galien Foum Monaco Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2016 Jim Scholefield Merck & Co., Inc. Executive Vice President, Chief Information & Digital Officer Galien Forum USA Delivering on the patient promise of gene therapy
2020 Rob Scott Abbvie Retired Chief Medical Officer Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2020 Jessica S. Scott Takeda Pharmaceuticals Head of R&D Patient Engagement Office Jerusalem Ethics Forum Tracking bioethics: transparency, trust & the industry’s social imperatives
2022 Rob Scott, Alcon Vice President, Intraocular Devices R&D Galien Week of Innovation Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2020 Theodore F. Search Skipta Chief Executive Officer Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2020 Theodore F. Search Skipta Chief Executive Officer Galien Week of innovation Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2021 Penda Seck Committee to Combat Violence against Women (CLVF) Senegal President Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2020 Annette Seck Ndiaye PNA Senegal Director Galien Forum Africa Covid 19 drug supply chain in africa: challenges & perspectives
2020 Sandi See Tai Pfizer Global Product Development Pfizer Inc. Vice President, Medicine Team Lead for Amyloid, Rare Neuro & Cardiac Galien Week of innovation The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2021 Amal El Fallah Seghrouchni Sorbone Universiti Intelegence Articielle Galien Webinars Series The impact of digital technology in clinical trials: ethical considerations (french edition)
2020 Adam Selamani Luxembourg Health Digital expert Galien Forum Africa What place for digital health & innovations? sub-theme 3:
2012 Dennis Selkoe Harvard Medical School; Center for Neurologic Diseases, Brigham & Women's Hospital,& Vincent & Stella Coates Professor of Neurologic Diseases, Co-Director Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2016 Magnus Settergren Karolinska Institutet & Karolinska University Hospital Stockholm Associate Professor, Interventional Cardiologist, Galien Forum USA The marriage of technology & medicine: bringing out the best in each other
2020 Dan Sexton Takeda Pharmaceutical Company Limited Strategy Lead Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2020 Moussa Seydi Clinic SMIT Head of Department of Infectious & Tropical Diseases Galien Forum Africa Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3:
2021 Stephanie Seydoux Global Health France Ambassador Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2020 Gaurav Shah Rocket Pharmaceuticals, Inc President & Chief Executive Officer Galien Forum USA The promise of gene therapy
2021 Javad Shahidi Daiichi Sankyo Vice President, Global Oncology R&D Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2020 Javad Shahidi Daiichi Sankyo Vice President, Global Oncology R&D Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
2021 Narinder S. Shargill Global Medical Affairs Vice President Galien Week of innovation What is med tech innovation doing for patients with specialized needs for treatment?
2016 Jonathan Sheldon Oracle Global Vice President, Healthcare, Health Sciences Global Business Unit, Galien Forum USA Precision medicine: delivering on the promise
2015 Jonathan Sheldon Oracle Health Sciences Global Vice President, Galien Forum USA Us health reform: partnering, pricing & politics
2014 Jonathan Sheldon Oracle Health Sciences Global Vice President, Galien Forum USA The brain initiative
2013 Jonathan Sheldon Oracle Health Sciences Global Senior Director of Translational Medicine, Galien Forum USA Personalized medicine: effect on drug r&d & patient care
2013 Morgan Sheng Genentech Vice President, Neuroscience, Galien Forum USA Neurodegenerative disease drug progress
2021 Michel  Sidibe African Medicines Agency AMA-UA International – Mali African Union Special Envoy Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2020 Michel Sidibe Mali Former Minister of Health Galien Forum Africa Health break
2018 Michel Sidibe UNAIDS Chief Executive Officer Galien Forum Africa Financing africa’s healthcare
2013 Elliott Sigal Bristol Myers Squibb Former Executive Vice President, Chief Scientific Officer & President, R&D Galien Forum USA Improving efficiency in drug development
2022 Cynthia Silva Outset Medical, Inc. Clinical Affairs Outset Medical Galien Week of Innovation Medical Devices and Implants - Other Therapeutic Areas What is Med Tech innovation doing for patients with specialized needs for treatment?
2011 Jonathan Silverstein OrbiMed Advisors Partner Galien Forum USA Funding innovation new trends in the healthcare m&a l& scape
2010 Jonathan Silverstein OrbiMed Advisors Partner Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2020 Ute Simon AAA ( a Novartis company) Head Global Medical Affairs Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2019 Nancy Simonian Syros Pharmaceuticals President & Chief Executive Officer Galien Forum USA What’s holding back the technology revolution in clinical trials?
2021 Peter  Singer  WHO DG International – Canada Special Advisor Galien Forum Africa Innovations & ethic for global health security
2020 Laksen Sirimanne Edwards Lifesciences Vice President, Research & Development Galien Week of innovation How much are new technologies & engineering efficiencies contributing to progress against the world’s biggest killer?
2022 Laksen Sirimanne Edwards Lifesciences R&D Transc Heart Valve Galien Week of Innovation Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2019 Daniel M. Skovronsky Eli Lilly Research Laboratories & Company President & Chief Scientific & Medical Officer, Galien Forum USA What’s holding back the technology revolution in clinical trials?
2015 Laura Slatkin New York Collaborates for Autism Co-Founder Galien Forum USA Autism - the next decade
2020 Martha Smit Private Pharmaceutical Sector South Africa Life Sciences, Africa Galien Forum Africa Place of local production in the pharmaceutical sector sub-theme 4:
2018 Martha Smit Life Sciences Practice group, Johannesburg Partner, Fasken; Member Galien Forum Africa Universal access to essential & others medicines
2019 Robin Smith STEM for Life Foundation, USA Founder Jerusalem Ethics Forum Ethical considerations around patient choice & human enhancement in healthcare?
2019 Robin Smith STEM for Life Foundation, USA Founder Jerusalem Ethics Forum “artificial intelligence & ethics”
2015 Robin L. Smith Neostem & Cura Foundation Founder Galien Forum USA Fireside chat | delivering on the patient promise of gene therapy
2022 Kimberly Smith ViiV Healthcare Sr VP Head of R&D Galien Week of Innovation Anti-Viral Drugs and Women’s Health With a global pandemic raising awareness of the importance of vaccines and anti-viral/anti-microbial drugs, are private-sector R&D incentives aligned to meet future contagion threats? Gauging unmet needs in women’s health therapeutics and promising new drugs in the development stage
2021 Kim Smith-Whitley GBT Executive Vice President & Head of Research & Development Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2022 Michael Sneed Johnson & Johnson Executive Vice President, Global Corporate Affairs & Chief Communication Officer Galien Webinars Series Golden Jubilee - Best BioTech Category
2020 Cheikh Sokhna Research Institute for Development (Senegal) Director of Research Galien Forum Africa Clinical trials in africa sub-theme 2:
2021 Apolline Sondo DITD of the University Hospital – Burkina Faso Head of the department of infectious & tropical diseases Galien Forum Africa Involvement of women researchers in the mhw
2020 Apolline Sondo Ouagadougou (Burkina Faso) Head of the Infectious & Tropical Diseases Department SMIT Galien Forum Africa Management of patients positive for sars-cov2: management, challenges & perspectives sub-theme 3:
2021 Vera Songwe UN Economic Commission for Africa International – Cameroon Executive Secretary Galien Forum Africa Symposium one health – one africa : a new agenda for governance & the growth of a post-covid continent
2022 Harpreet Sood Huma VP, Primary Care & Clinical Partnerships - Moderator Galien Week of Innovation Digital Health Solution - Clinical Trial Management and Wellness Care Are researchers, physicians and regulators ready to embrace advanced, low-touch approaches to streamline the cumbersome infrastructure of clinical trials? And are insurers and health systems prepared to reward software- driven patient self-care technologies, particularly by recognizing prevention and wellness as an integral element of service provision?
2021 Yaye Sophietou Diop Speak Up Africa – Senegal Advocacy Specialist Galien Forum Africa The power of youth: how can young leaders contribute to sustainable change for healthier communities?
2011 Pascal Soriot AstraZeneca Chief Executive Officer Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2020 Jonathan Sorof Global Blood Therapeutics Senior Vice President, Head of Medical Affairs Galien Week of innovation Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?
2020 Lukas K. S Sosoe University of Luxembourg Teacher Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2021 Quentin Soulet De Brugiere Dreem Co-Founder & Chief Executive Officer Galien Week of innovation Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2020 Mohamed Soumah Organ Transplantation & Donation Commission (Senegal) Head of the Department of Forensic Medicine & member Galien Forum Africa Current situation of the response, challenges & prospects.sub-theme 1:
2021 Khoudia Sow UCAD Senegal President Galien Forum Africa Socio-economic consequences, equity & gender in the global health security
2021 Samba Sow Vaccine Development Center (CVD), Minister of Health, Mali Director General Galien Forum Africa Communication of crisis or risk communication & community engagement (rcce) : what respective roles ?
2020 Papa Salif Sow Program Development & Management, Access Operations & Emerging Markets, Africa / Geneva. GILEAD sciences Vice President Galien Forum Africa Vaccine production: state of play & perspectives sub-theme 4
2020 Mouhamadou Sow Teranga Pharma «Ensuring the pharmaceutical sovereignty of Senegal» Managing Director Galien Forum Africa Place of local production in the pharmaceutical sector sub-theme 4:
2020 Jeffrey Spaeder IQVIA Chief Medical & Scientific Officer & Senior Vice President Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2019 Jeffrey Spaeder IQVIA Chief Medical & Scientific Officer & Senior Vice President Galien Forum USA What’s holding back the technology revolution in clinical trials?
2013 Reisa Sperling Harvard Medical School Department of Neurology, Brigham & Women’s Hospital Neurology Galien Forum USA Neurodegenerative disease drug progress
2020 Sam Spigelman Janssen Research & Development, LLC Senior Global Medical Affairs Leader Galien Week of innovation What are the prospects – & limitations – behind the new approaches to cancer treatments from our increased knowledge of the underlying biology behind tumor growth & proliferation?
2022 Sanjay Srivastava Accenture Managing Director LifeSciences Moderator Galien Week of Innovation Solid Tumor Cancers What is the state of progress in extending cell-based gene therapies to fight solid tumor cancers? How successful has the pharma industry been in building new therapeutic and diagnostic platforms to fight major cancers and address their prevalence in vulnerable populations, including the aged, minorities, and pediatric patients?
2021 Nagaraja Srivatsan IQVIA Senior Vice President & Chief Digital Officer, R&DS Technology Solutions Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-22
2021 Nagaraja Srivatsan IQVIA Senior Vice President & Chief Digital Officer, R&DS Technology Solutions Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-19 part 6
2021 Nagaraja Srivatsan IQVIA Senior Vice President & Chief Digital Officer, R&DS Technology Solutions Galien Week of innovation Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2022 Neil Stahl Regeneron EVP, Research and Development Galien Week of Innovation Laureates Media Presentation
2014 Jay Stamatis AbbVie Vice President, Corporate Strategy Office; Head of Business Development & Acquisitions, Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2015 Glenn D. Steele Jr. Geisinger Health System Chairman, xG Health Solutions; Former Chief Executive Officer Galien Forum USA Us health reform: partnering, pricing & politics
2015 Glenn D. Steele Jr. Geisinger Health System Chairman, xG Health Solutions; Former Chief Executive Officer Galien Forum USA Delivering on the patient promise of gene therapy
2014 Steven H. Stein Novartis Oncology US Senior Vice President, US Clinical Development & Medical Affairs, Galien Forum USA Cancer immunotherapeutics
2021 Sally Stephens Medicines360 Corporate Strategy, Business Development, Marketing/Sales, & the Developing Countries Program Galien Week of innovation Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against chronic conditions that kill millions?
2012 Scot Stevens UPMC CancerCenter & UPCI,Director Personalized Medicine Technology, Chief Information Officer Galien Forum USA Addressing big datachallenges in genomics & personalized healthcare
2020 Paul Stoffels Johnson & Johnson Vice Chairman of the Executive Committee & Chief Scientific Officer - Galien Forum USA Covid-19 vaccines: the path to the holy grail
2022 Jayme Strauss Viz.ai Chief Clinical Officer Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2012 Eliane Strosberg Art & Science - Belgium Professor Galien Forum USA Art & science: from anatomy to genetics
2015 Lorenz Studer The Center for Stem Cell Biology Developmental Biology Program, The Memorial Sloan-Kettering Cancer Center Director Galien Forum USA Untangling the web of neurodegeneration: how far & how soon?
2021 Harrison Suhnfor H&S Technologies – Cameroun Young Innovators Galien Forum Africa Meeting of young innovators with investors
2021 Mark Sullivan Medicines Development for Global Health Founder & Managing Director Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines & anti-viral/anti-microbial drugs, are private-sector r&d incentives aligned to meet these unmet medical needs?
2020 Mark Sullivan Medicines Development for Global Health Founder & Managing Director Galien Week of innovation Will the coronavirus pandemic finally lead to an upswing in r&d to tackle neglected areas like antibiotic resistance, zoonotic transmission of pathogens & a more globally-coordinated approach to infectious diseases overall?
2012 Anthony Sun Aisling Capital Partner Galien Forum USA The changing face of chinese healthcare
2022 Sally Sussman Pfizer Chief Corporate Affairs Officer, Executive Vice President Galien Webinars Series Golden Jubilee - Best Vaccine Category
2020 Soumya Swaminathan World Health Organization Chief Scientist Jerusalem Ethics Forum Societal, legal & ethical challenges around access to covid-19 vaccines
2015 Julie Sweet Accenture Chief Executive Officer & Chair of the Board Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2020 Abdou Aziz Sy Sabodala Gold Managing Director Galien Forum Africa Impact of the covid 19 pandemic on the natural resources sector sub-theme 2:
2021 Cheikna Sylla CODES & Honorary Director of the UFR of Health Sciences of Thies – Senegal President Galien Forum Africa Conference on reform in health training
2011 Kevin Tabb Stanford Hospital & Clinics Chief Medical Officer Galien Forum USA Perspectives on innovation, patient safety & global access thinking beyond laboratories & clinical trials
2022 Ramita Tandon Walgreens Chief Clinical Trials Office Galien Week of Innovation Best Incubator/Accelerator/ equity - Clinical Trial Management and Wellness Care An innovator’s connection to a leadership accelerator, incubator or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities or build a go-to marketing plan? Beyond access to cash, what makes the innovator’s connection to an accelerator, incubator or private equity group success critical?
2018 Hong Tang Pasteur Institute of Shanghai Director Galien Forum Africa Remarkable women engage for humanity
2018 Hong Tang Pasteur Institute of Shanghai Director Galien Forum Africa managing infectious diseases & pandemics
2021 Conrad Tankou GIC Space Chief Executive Officer Galien Forum Africa Leadership & innovation, meet the winners of the africa young innovators award for health
2010 Mary Tanner Peter J. Solomon Company Managing Director Galien Forum USA Biomedical innovation: funding challenges & developing public/private partnership incentives
2022 Marc Taub Abbott Divisional VP Technical Operations Galien Week of Innovation Laureates Media Presentation
2015 Marti Taylor OneFifteen President & Chief Executive Officer Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2020 Alain Tehindrazanarivelo African Regional Expert Committee on Traditional Medicine (Madagascar) Neurologist & member Galien Forum Africa Contribution of traditional medicine in the response against covid 19: state of play, challenges & prospects sub-theme 5:
2021 Pamela Tenaerts Medable, Inc Chief Scientific Officer Galien Week of innovation How far are we from achieving the health system world of the connected patient?
2015 Marc Tessier-Lavigne The Rockefeller University, New York, President, Professor Laboratory of Brain Development & Repair Galien Forum USA Untangling the web of neurodegeneration: how far & how soon?
2015 Marc Tessier-Lavigne The Rockefeller University, New York, President, Professor Laboratory of Brain Development & Repair Galien Forum USA Delivering on the patient promise of gene therapy
2014 Marc Tessier-Lavigne The Rockefeller University, New York, President, Professor Laboratory of Brain Development & Repair Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2013 Marc Tessier-Lavigne The Rockefeller University, New York, President, Professor Laboratory of Brain Development & Repair Galien Forum USA Presentation of the pershing square sohn prize for young investigators in cancer research in new york city
2013 Marc Tessier-Lavigne The Rockefeller University, New York, President, Professor Laboratory of Brain Development & Repair Galien Forum USA Neurodegenerative disease drug progress
2021 Sanskriti Thakur Medable Chief Growth Officer Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2021 Sanskriti Thakur Medable Chief Growth Officer Jerusalem Ethics Forum Inclusive medicine: how modern research amplifies outcomes for patient access, inclusion & diversity
2022 Sans Thakur Medable Chief Growth Officer Moderator Galien Week of Innovation Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2018 Ibrahima Thiaw Sahel Special Advisor Galien Forum Africa The health consequences of climate change
2018 Mame Thierno Dieng Senegal Minister of the Environment Galien Forum Africa The health consequences of climate change
2012 William Thies Alzheimer's Association Chief Medical & Scientific Officer Galien Forum USA Alzheimer's innovation & the white house 2025 m& ate:what will it take to find a treatment?
2021 Elizabeth H.Z. Thompson Horizon Research & Development Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2016 Craig Thompson Memorial Sloan-Kettering Cancer Center , President & Chief Executive Officer Galien Forum USA Promise - & politics - in the fight against cancer
2020 Mads Krogsgaard Thomsen Novo Nordisk A/S Executive Vice President & Chief Scientific Officer Galien Forum USA The future of therapeutics: what novel modalities will be drugs? what vaccines & technologies will we need?
2018 Madeleine Thomson Wellcome Trust Head of Climate Impacts Galien Forum Africa The health consequences of climate change
2011 Nancy Thornberry Kallyop Chief Executive Officer Galien Forum USA The gut microbiome: opportunities & challenges
2020 Ramon Tiu Astellas Pharma Global Development Global Medical Leader, Gilteritinib Program Executive Medical Director Galien Week of innovation Are there common links in advancing research on hematologic cancers & other rare diseases associated with uncontrolled vascular system inflammation, such as sickle cell anemia?
2022 Jaya L. Tiwari XVIVO Perfusion Clinical & Regulatory Affairs Galien Week of Innovation Biotech - Chronic/Autoimmune Disorders and Vaccines Given that many chronic diseases have an infectious origin, what learnings can be had by the most recent innovations in vaccine development technology in raising the bar on innovations to address the huge unmet need against conditions that kill millions?
2011 Eric Topol Scripps Research Translational Institute, Author, Deep Learning Executive Vice President & Chair of Innovative Medicine, Director & Founder Galien Forum USA The marriage of technology & medicine: bringing out the best in each other
2021 Emma Toure Cuq URGOTech Inc. Chief Scientific Officer Galien Week of innovation Are insurers & health systems ready to embrace & reward these new self-care technologies, particularly in recognizing prevention & wellness as an integral element of service provision?
2021 Coumba Toure Kane University of Sine Saloum – Senegal IRESSEF, Chancellor Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 7
2014 Olivia Tournay Flatto Pershing Square Sohn Cancer Research Alliance Executive Director  Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2015 Kevin J. Tracey The Feinstein Institute for Medical Researc President  Galien Forum USA Bioengineering for better health: what future for targeted drug delivery?
2019 Tomasz Trafny Vatican Official of the Pontifical Council for Culture Jerusalem Ethics Forum Ethical considerations around patient choice & human enhancement in healthcare?
2019 Tomasz Trafny Pontifical Council for Culture, Vatican Head of Science & Faith Department Jerusalem Ethics Forum “artificial intelligence & ethics”
2022 Thomas Triomphe Sanofi-Pasteur MSD VP, Vaccines Galien Webinars Series Golden Jubilee - Best Vaccine Category
2014 Nathaniel Turner Flatiron Health, Inc. Co-Founder Galien Forum USA The future of digital health
2014 Stephen J. Ubl PhRMA President & Chief Executive Officer Galien Forum USA Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2021 Marie Chantal Umunyana Women Innovators Incubator program Participant Galien Forum Africa Women & stem in the global health security context
2021 J.P. Urbanski Baylis Medical Director of Strategic Marketing Galien Week of innovation How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2022 J.P. Urbanski Boston Scientific | Baylis Medical Dir Strategic Mkg Cardiology Baylis Galien Week of Innovation Medical Devices and Implants – Cardiovascular and Cancer How are systems design, electronics and engineering making invasive, high-risk surgical procedures a thing of the past for these two major killers?
2021 Juan Pablo Uribe Global Financing Facility GFF International – Colombia Director Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 8
2022 Giovanna Usvardi Chiesi Group Head of Global Communication & Public Affairs Galien Webinars Series Golden Jubilee - Best Orphan Rare Category
2014 Roy Vagelos Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc Chairman Galien Forum USA Us health reform
2013 Roy Vagelos Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc Chairman Galien Forum USA Keynote: drug pricing & access in the trump administration: consensus or confrontation?
2013 Roy Vagelos Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc Chairman Galien Forum USA Intro
2013 Roy Vagelos Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc Chairman Galien Forum USA Affordable care act us healthcare in transition: the stakes for industry
2012 Roy Vagelos Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc Chairman Galien Forum USA Welcome
2012 Roy Vagelos Prix Galien USA; Regeneron Pharmaceuticals ; Merck & Co., Inc Chairman Galien Forum USA Panel: “looking back, moving forward”
2022 Patrick Vallance Government Government Chief Scientific Adviser Galien Forum UK Access to innovation: optimizing health for patient populations
2022 Jérôme Van Biervliet VIB Managing Director Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2022 Filip Van den Wyngaert Sanofi MSc Global Head TTP Galien Week of Innovation BioTech – Rare Diseases What is the underlying science behind clinical progress in therapies that promise a genetics-based cure for devastating rare diseases and how will this contribute to the next wave of innovations? What are the implications for continued patient access to these high-cost, high-touch 2 treatments – does the ROI calculation for rare diseases still add up?
2022 Lisette Van Gemert University of Twente. Professor Galien Forum Netherlands #VALUE!
2022 Roderick Van Grieken The Netherlands Debate Institute Founder & Director Galien Forum Netherlands #VALUE!
2020 Katherine Vandebelt Oracle Health Science Global Vice President, Clinical Innovation Galien Week of innovation The ability to claim larger health system productivity benefits from the introduction of chronic disease medicines looms in importance as these therapeutic segments become more crowded & competitive.
2022 Ashkan Vaziri BioSensics Founder, CEO Galien Week of Innovation Digital Health Solution - Disease Management In what ways can these new technologies contribute to the realization of better outcomes for patients at less cost to overburdened health systems?
2021 Rajeev Venkayya Takeda Pharmaceuticals Ltd. President, Global Vaccines Unit Jerusalem Ethics Forum Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2013 Rajeev Venkayya Takeda Pharmaceuticals Ltd. President, Global Vaccines Unit Galien Forum USA Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2021 Michele Verschoore L’Oreal Research & Innovation (France) Medical Director Galien Forum Africa Involvement of women researchers in the mhw
2019 Michele  Verschoore L’Oreal Research & Innovation (France) Medical Director Jerusalem Ethics Forum Personalized genomics medicine: the value of knowing
2016 Philip Vickers Shire plc Global Head, Research & Development Galien Forum USA Precision medicine: delivering on the promise
2014 Christopher A. Viehbacher Sanofi & Chairman Genzyme Chief Executive Officer Galien Forum USA Us health reform
2022 Pam Vig Mirum Pharmaceuticals, Inc. Head of R&D Galien Week of Innovation Rare Genetic Diseases Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high-cost, high-touch treatments?
2022 Michael Vincent Pfizer Inc. SVP CSO In & Immuno Galien Week of Innovation Chronic and Autoimmune Disorders Chronic non-communicable diseases now account for three quarters of annual deaths worldwide, with a fast rising percentage taking place in low and middle income countries. With this in mind, how important is incentivizing more industry investment in costly clinical trials and other research targeting key areas of unmet need in major chronic conditions like CVD? Will a better understanding of the common molecular signatures that underlie many serious autoimmune disorders result in more progress in therapeutic interventions, including prevention?
2013 Bert Vogelstein Johns Hopkins School of Medicine Professor of Oncology Galien Forum USA Keynote Personalized medicine: effect on drug r&d & patient care
2019 Andrew C. Von Eschenbach Samaritan Health Initiatives, Inc., USA President Jerusalem Ethics Forum Health policy & financing innovation: ethical considerations, cost & the role of the patient
2019 Andrew C. Von Eschenbach Samaritan Health Initiatives, Inc., USA President Jerusalem Ethics Forum Dominion over all of creation: progress & responsibility
2019 Andrew C. Von Eschenbach Samaritan Health Initiatives, Inc., USA President Jerusalem Ethics Forum 2020/2030 agenda “facing the next ethical challenges”
2014 Robert H. Vonderheide Perelman School of Medicine, University of Pennsylvania Hanna Wise Professor of Cancer Research , Galien Forum USA Cancer immunotherapeutics
2019 Michel Vounatsos Biogen inc Chief Executive Officer & Director Galien Forum USA The gut microbiome: opportunities & challenges
2015 Michel Vounatsos Biogen Chief Executive Officer Galien Forum USA Delivering on the patient promise of gene therapy
2018 Salimata Wade University Cheikh Anta Diop - Senegal Nutritionist Galien Forum Africa Addressing chronic malnutrition
2022 Mel Walker MW Consulting Biotech/Digital Health Adviser Galien Forum UK Access to innovation: optimizing health for patient populations
2022 Mark Walport Imperial College, London UK Honorary Distinguished Professor of Medicine Galien Forum UK Welcome Remarks
2014 Sihong Wang City University of New York City College Prize Winner & Associate Professor of Biomedical Engineering, Galien Forum USA Pioneers for a cure: the role of innovation & entrepreneurship in cancer research
2021 Rhoda Wanyenze School of Public Health & College of Health Sciences, Makerere University – Uganda Dean Galien Forum Africa Covid 19 lessons learned, autonomy & sovereignty of africa sub topic 9
2020 Majesty Ihou Wateba Health Sciences of the University of Lome (Togo) Minister of Health & Dean of the Faculty Galien Forum Africa Socio-economic impact of the covid 19 pandemic sub-theme 5
2017 Ryan Watts Denali Therapeutics Co-founder, President & Chief Executive Officer Galien Forum USA Addressing unmet medical needs with early-stage life science venture capital
2015 Ryan Watts Denali Therapeutics Co-founder, President & Chief Executive Officer Galien Forum USA Untangling the web of neurodegeneration: how far & how soon?
2021 Scott C. Weaver University of Texas Medical Branch John Sealy Distinguished University Chair in Human Infections & Immunity Chair, Department of Microbiology & Immunology Director, Institute for Human Infections & Immunity; & Scientific Director Galveston National Laboratory GVN Center Director Jerusalem Ethics Forum Highly prevalent neglected diseases: developing medicines & building infrastructure for the rest of the world
2021 Iain Webb Bayer Head of US Medical Affairs Oncology Galien Week of innovation Will the success of novel, gene-based therapies in advancing survival timelines in blood & bone marrow cancers be repeated in the solid tumor setting, with therapies that address each tumor’s individual genetic profile rather than association with its geographic location in the body?
2021 Iain Webb Bayer Head of US Medical Affairs Oncology Galien Week of innovation What is the state of progress in building new therapeutic & diagnostic platforms to fight major cancers & address their prevalence in vulnerable populations, including the aged, minorities, & pediatric patients?
2015 Christophe Weber Takeda Pharmaceutical Company Limited PharmD, Representative Director, President & Chief Executive Officer, Galien Forum USA How will we be paying for medicine 10 years from now? (Chief Executive Officers panel)
2022 Michelle Weese Bristol-Myers Squibb EVP, Corporate Affairs Galien Webinars Series Golden Jubilee - Best BioTech Category
2020 Tal Wenderow VOCALIS HEALTH Chief Executive Officer Galien Webinars Series The digital health enterprise: start-up trends & the culture of big pharma
2011 Robert M. Wenham Moffitt Cancer Center Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental Therapeutics Galien Forum USA The next generation of health & research informatics accelerating translational research & personalized medicine at moffitt cancer center
2019 Steve Whitehead NIH National Institute for Allergies & Infectious Diseases Senior Associate Scientist, Laboratory of Infectious Diseases, Galien Forum USA Preparing for the next pandemic: development & delivery of new wave innovations in vaccines
2018 Marion Wiesel The Elie Wiesel Foundation for Humanity New York Chair Galien Forum Africa Remarkable women engage for humanity
2012 Elie Wiesel Author & Peace Nobel Prize Laureate Professor Galien Forum USA Ethics of innovation, under the auspices of the elie wiesel foundation for humanity
2022 Roy Wiesner aMoon Fund Managing Director Galien Week of Innovation Best Incubator/Accelerator/ equity - Disease Management Incubators and accelerators are pivotal in developing innovative solutions to address humanity’s most pressing health challenges. Why are academic institutions, major medical centers, and significant life science companies launching incubators and accelerators to offer guidance to biotech, digital health, health information, and medical device start-ups? Beyond financial resources, how are these groups working to advance ideas into the marketplace, and what is their impact?
2020 Roy Wiesner aMoon Managing Director Galien Webinars Series The digital health enterprise: start-up trends & the culture of big pharma
2022 Chris Williams Sanofi Head of Corporate Communications & Brand Galien Webinars Series Golden Jubilee - Best Pharmaceutical Category
2021 Alisa Wilson Accenture Managing Director, Life Sciences Galien Week of innovation Can the foundational biologic underst& ings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other rare conditions, particularly blood-based hematologic disorders?
2011 Ron Winslow WSJ Senior Medical & Health Care Writer Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2021 Pascale Witz Sanofi et PDG de GE Pharmaceutical Diagnostic Founder & CEO Galien Webinars Series The impact of digital technology in clinical trials: ethical considerations (french edition)
2015 Amanda Woerman Institute for Neurodegenerative Diseases, (UCSF) Assistant Professor of Neurology Galien Forum USA Closing symposium: treating neurodegenerative disease: the potential of prion-based therapies
2020 Cen Xu Amgen Neuroscience Executive Director Galien Week of innovation Where is the growing science & its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?
2022 George Yancopoulos Regeneron Co-Founder, president and chief scientific officer Galien Forum USA CEO Panel
2020 George Yancopoulos Regeneron Pharmaceuticals President & Chief Scientific Officer - Galien Forum USA Immunology from both sides: oncology & autoimmune disease
2017 George Yancopoulos Regeneron Pharmaceuticals President, & Chief Scientific Officer, Galien Forum USA Inflammatory skin diseases & mechanistic interconnections to other inflammation disorders
2021 Nadim Yared CVRx President & Chief Executive Officer Galien Week of innovation How are systems design, electronics & engineering making invasive, high-risk surgical procedures a thing of the past?
2018 Yazdan Yazdanpanah Inserm Professor Galien Forum Africa managing infectious diseases & pandemics
2018 Yazdan Yazdanpanah Inserm Professor Galien Forum Africa Remarkable women engage for humanity
2021 Ashley Yegin Takeda Global Medical Unit Head, Rare Disease/HAE Galien Week of innovation Will clinical progress in therapies that promise a genetics-based cure for devastating rare diseases lead to similar downstream progress in patient access to these high-cost, high-touch treatments?
2014 Krishna Yeshwant Google Ventures General Partner Galien Forum USA The future of digital health
2021 Tal Zaks Moderna Chief Medical Officer Galien Webinars Series The impact of digital technologies in transforming & accelerating vaccine trials, development & delivery – lessons from covid-23
2022 Nafeez Zawahir Publicis Chief Medical Officer - Moderator Galien Week of Innovation Laureates Media Presentation
2011 Jide Zeitlan Keffi Group Chief Executive Officer Galien Forum USA Funding innovation new trends in the healthcare m&a l& scape
2014 Elias Zerhouni Sanofi President, Global R&D. Galien Forum USA A new agenda for global health
2015 Feng Zhang Massachusetts Institute of Technology Professor Galien Forum USA Delivering on the patient promise of gene therapy
2021 Eyal Zimlichman ARC Innovation Program Founder & Director Galien Webinars Series The incubators of innovation: academic medical centers as digital health champions
2016 Bernard Zinman Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Sinai Centre for Diabetes. Mount Sinai Hospital, Toronto, Ontario Senior Scientist Director of the Leadership Galien Forum USA Diabetes mellitus & cardiovascular risk – on the rise, fall & novel possibilities with glucose lowering drugs
2013 Huda Zoghbi Baylor College of Medicine Professor Galien Forum USA Personalized medicine: effect on drug r&d & patient care
2022 Lynne Zydowsky Alexandria summit; chief of science, Alexandria real estate equities, inc./Alexandria venture investments Chief Science Officer Galien Forum USA Mental health in America, a public health crisis
2021 Lynne Zydowsky Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments Chief Science Officer Galien Forum USA Combating the opioid crisis in america
2020 Lynne Zydowsky Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Chief Science Officer Galien Forum USA Covid-19 vaccines: the path to the holy grail
2018 Lynne Zydowsky Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Chief Science Officer Galien Forum USA Cancer in a time of disruption
2017 Lynne Zydowsky Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Chief Science Officer Galien Forum USA Addressing unmet medical needs with early-stage life science venture capital
2014 Lynne Zydowsky Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Chief Science Officer Galien Forum USA The future of digital health
2011 Lynne Zydowsky Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments ; Co-Founder, Alexandria Summit Chief Science Officer Galien Forum USA A global health challenge: the obesity & diabetes epidemic where are the innovations & who will pay for them?
2014 Thierry Zylberberg Orange Healthcare Executive Vice President Galien Foum Monaco Beyond the Pill : The digital transformation of the biopharmaceutical industry in progress
2023 Jane Adam St. George’s NHS Trust NICE Technology Appraisal Committee and Consultant, Galien Forum UK What is the role of the NHS in public sector innovation?
2023 Lucy Chappell Department of Health & Social Care (DHSC) Chief Scientific Adviser Galien Forum UK What is the role of the NHS in public sector innovation?
2023 Ara Darzi of Denham Imperial College London Co-Director, Institute of Global Health Innovation, Galien Forum UK impact of AI / Digital on healthcare
2023 Luisa Freitas Dos Santos GSK Vice President - Global Clinical Supply Chain, Galien Forum UK Driving resilience in global medical supply chains
2023 Will Gibbs Octopus Ventures Healthtech Partner, Galien Forum UK impact of AI / Digital on healthcare
2023 Alison Holland Medable Executive GM, Digital and Decentralized Solutions, Galien Forum UK impact of AI / Digital on healthcare
2023 Sarah Justine Kerruish Kheiron Medical Technologies Chief Strategy Officer, Galien Forum UK impact of AI / Digital on healthcare
2023 Stephanie Kuku World Health Organization’s Department of Digital Health and Innovation Health Technology Director, Senior Consultant, Hardian Health & Senior Adviser and Consultant, Galien Forum UK impact of AI / Digital on healthcare
2023 Ravi Limaye Wockhardt UK CEO / Managing Director, Galien Forum UK Driving resilience in global medical supply chains
2023 Murray Lumpkin Bill & Melinda Gates Foundation Lead for Global Regulatory Systems Initiatives Galien Forum UK Access to innovation: exploring solutions to global challenges.
2023 Deusdedit Mubangizi World Health Organization Head of Prequalification Unit Galien Forum UK Access to innovation: exploring solutions to global challenges.
2023 Munir Pirmohamed University of Liverpool David Weatherall Chair of Medicine, Galien Forum UK Driving resilience in global medical supply chains
2023 Sam Roberts National Institute for Health and Care Excellence Chief Executive Officer Galien Forum UK Access to innovation: exploring solutions to global challenges.
2023 Roland Sinker Cambridge University Hospitals NHS Foundation Trust Chief Executive Galien Forum UK What is the role of the NHS in public sector innovation?
2023 Helen Stokes Lampard Academy of Medical Royal Colleges Chair Galien Forum UK What is the role of the NHS in public sector innovation?
2023 Steffen Thirstrup European Medicines Agency Chief Medical Officer Galien Forum UK Access to innovation: exploring solutions to global challenges.
2023 Per Troein IQVIA Vice President Strategic Partners, Galien Forum UK Driving resilience in global medical supply chains
2023 Mel Walker Biotech/Digital Health Adviser Galien Forum UK Access to innovation: exploring solutions to global challenges.
2023 Bruce Warner NHS Deputy Chief Pharmaceutical Officer for England, Galien Forum UK Driving resilience in global medical supply chains
2023 Matthieu Leclerc-Chalvet Therapixel CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Rich Brancaccio Revibe Technologies Founder, Chief Innovation Officer Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 anam Shetty Evolve Medical Systems Founder, CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Rebecca Wilkins Abbott - NeuroSphere Virtual Clinic Divisional Vice President, Research & Development Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Sharief Taraman Cognoa CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Shailja Dixit Curio CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Eric Dessertenne Biocorp CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Alexander Riftine IntelleWave President, CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Mette Dyhrberg Mymee Founder, CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Eran Orr XRHealth CEO Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Ryan Brewster NoviGuide NoviGuide Clinical Consultant Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 MaryAnn Rizk Rizk Management Advisors CEO - Moderator Galien Week of innovation What factors have contributed to the slower than anticipated take-up of digital health offerings in the management of chronic disease? Is AI going to finally tip the scale and lead to universal adoption of “connected health” strategies focused on digital therapeutics?
2023 Chrissa McFarlane Patientory, Inc Founder, CEO Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Roy Cohen Behavidence CEO Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Eric Snyder Hyperion Director, Informatics / Technology Innovation Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Michelle Longmire Medable Co-Founder, CEO Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Darcy Forman Science 37 Chief Delivery Officer Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Zahid Ali Ashraf TECHMEDO Founder, CEO Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Marisa Cruz Empatica Chief Medical Officer Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Joe DeVivo Butterfly Network, Inc President, Chairman, Chief Executive Officer Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Madeline Naylor Skipta CR, CTM - Moderator Galien Week of innovation Are health system payers and insurers prepared to reward software-driven patient self-care applications, particularly by recognizing prevention and wellness as an integral element of service -- and reimbursement -- provision?
2023 Steven Lester, M.D. Mayo Clinic and Arizona State University MedTech Accelerator Founder, Chief Medical Officer Galien Week of innovation Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023 Gene D. Morse, PharmD Center for Integrated Global Biomedical Sciences by University at Buffalo Director, Center for Integrated Global Biomedical Sciences Galien Week of innovation Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023 Danina Kapetanovic OROT CONNECTED HEALTH INCUBATOR BY CIUSSS WEST CENTRAL MONTREAL Chief Innovation Officer Galien Week of innovation Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023 Konrad Dobschuetz NHS Innovation Accelerator National Director Galien Week of innovation Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023 Gil Bashe FINN Partners Managing Partner, Chair Global Health Purpose - Moderator Galien Week of innovation Incubator and accelerators are pivotal in developing innovative solutions to addressing humanity’s most pressing health care challenges. Why are academic institutes, major medical centers/ hospitals, and the top 10 pharma companies launching incubators and accelerator ventures to offer guidance to biotech, digital health, health information, and medical device start-ups, often under their own umbrella? Beyond financial and intellectual resources, how are these groups working to advance ideas into the marketplace, and what is their actual clinical impact?
2023 Isaac Middelmann EIT Health Venture Centre of Excellence (VCoE) Managing Director (ad interim) Galien Week of innovation An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023 Christopher Hentschel Cube Labs Chief Scientific Officer Galien Week of innovation An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023 Robert Karanja, PhD Villgro Africa Co-Founder Galien Week of innovation An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023 Mati Gill AION Labs CEO Galien Week of innovation An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023 Ron Cohen Acorda Therapeutics President, CEO - Moderator Galien Week of innovation An innovator’s connection to a leadership accelerator, incubator, or private equity organization is a strong indicator of success. Financial support is part of the commitment, as are experience and business connections. How do these investment and counseling groups help start-ups with their clinical trial design, navigate regulatory and payer system complexities, or build a go to marketing plan? Beyond access to cash, what makes the innovator’s connection to an incubator, accelerator, or private equity group so critical to eventual success in the market?
2023 Jim Lee Incyte Corp. Group Vice President, Head Inflammation and AutoImmunity Galien Week of innovation Gastrointestinal and adenocarcinoma cancers represent more than a quarter of all cancers. What are the epidemiological, cellular and molecular factors that are driving this trend, particularly among younger populations – and how is research science responding?
2023 Lamine Mbow Boehringer Ingelheim SVP, Global Head of Cancer Immunology BI - Moderator Galien Week of innovation Gastrointestinal and adenocarcinoma cancers represent more than a quarter of all cancers. What are the epidemiological, cellular and molecular factors that are driving this trend, particularly among younger populations – and how is research science responding?
2023 Patrice Lee Pfizer Inc. Vice President, Pharmacology, Toxicology and Exploratory Development Galien Week of innovation Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023 Susan Pandya Servier Pharmaceuticals Head of Cancer Metabolism Global Development Oncology & Immuno-Oncology Galien Week of innovation Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023 Robert Consalvo H1 Senior Director of Strategic Commercial Engagement - Moderator Galien Week of innovation Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023 Josh Bauml Janssen Pharmaceutical Companies of Johnson & Johnson Global Medical Head Amivantamab NSCLC Program Galien Week of innovation Assessing the current state of scientific progress in understanding the basic evolution of cancer as well as nominee experience in moving promising drug targets into clinical trials, regulatory approvals and market acceptance.
2023 Lewis Warrington, MD Ironshore Chief Medical Officer Galien Week of innovation CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success?
2023 Machelle Manuel, PhD Amylyx Pharmaceuticals, Inc. Vice President, Head Global Medical Affairs Galien Week of innovation CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success?
2023 Hugh Marston Boehringer Ingelheim Head of Global CNS Diseases - Moderator Galien Week of innovation CNS drugs often take longer to develop and have lower success rates than other types of drug candidates. What strategies are nominees developing to “de-risk” novel CNS therapies and speed the pathway to clinical and market success?
2023 Jessica Federer Chief Digital Officer - Moderator Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines and anti-viral medicines, are private-sector R&D incentives aligned to meet growing market needs? Gauging unmet needs in women’s health therapeutics and promising new trends in research.
2023 Jared Baeten Gilead Sciences, Inc. Vice President, Clinical Development, HIV Franchise Head Galien Week of innovation With a global pandemic raising awareness of the importance of vaccines and anti-viral medicines, are private-sector R&D incentives aligned to meet growing market needs? Gauging unmet needs in women’s health therapeutics and promising new trends in research.
2023 Francisco Leon Sanofi Chief Scientific Officer & Co-Founder, Provention Bio Galien Week of innovation Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023 Paulo Fontoura Genentech SVP and Global Head of Neuroscience and I2O Galien Week of innovation Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023 Mike Vincent Pfizer Inc. Senior Vice President, Chief Scientific Officer, Inflammation & Immunology (I&I) Galien Week of innovation Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023 Michael Ringel Boston Consulting Group (BCG) Managing Director, Senior Partner - Moderator Galien Week of innovation Given the complex biological and genetic interrelationships that characterize autoimmune, metabolic and aged-based genetic disorders, how has research science progressed in ensuring patients with these conditions can benefit from a more personalized approach to treatment?
2023 Bill Mezzanotte CSL / uniQure EVP, Head of Research and Development Galien Week of innovation Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023 Arup amanik Boehringer Ingelheim Corporate Vice President Galien Week of innovation Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023 Monica Kumar Sanofi Global Project Head Galien Week of innovation Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023 Bahija Jallal Immunocore CEO Galien Week of innovation Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023 Kevin Brubacher Bionest Partners, Accenture Managing Director - Moderator Galien Week of innovation Will progress in medicines that promise a cure for devastating rare diseases lead to similar innovations on patient access to these increasingly high-cost, high-touch therapies?
2023 Tonya Resutek Olympus America Inc. Executive Director for Respiratory Marketing Galien Week of innovation How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023 David Webster Body Vision Medical CEO Galien Week of innovation How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023 David Brachman GT Medical Technologies, Inc. Co-Founder and Chief Technology Officer Galien Week of innovation How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023 Madeline Naylor Skipta Wellness Care - Moderator Galien Week of innovation How are MedTech innovations like precision robotic engineering, connected devices, 3D printing and AI changing clinical workflows, costs and patient outcomes in cancer?
2023 Jason Spees Impulse Dynamics CEO Galien Week of innovation What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023 Laksen Sirimanne Edwards Lifesciences Senior Vice President, THV Research and Development Galien Week of innovation What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023 Matt Thompson ENDOLOGIX LLC CEO, President Galien Week of innovation What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023 Anew Easton Terumo Aortic Senior Global Product Manager Galien Week of innovation What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023 Robert Consalvo H1 Senior Director of Strategic Commercial Engagement - Moderator Galien Week of innovation What do MedTech manufacturers require to ensure that patients continue to benefit from safer, less invasive innovations in CVD, still the number one cause of death worldwide?
2023 Steven Eror Solo-Dex, Inc. Chief Executive Officer Galien Week of innovation What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023 Jennifer Sipple Outset Medical, Inc. Vice President, Marketing Galien Week of innovation What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023 Arthur Rascon Valencia Technologies Corporation Chief Executive Officer Galien Week of innovation What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023 Gil Bashe FINN Partners Managing Partner Chair Global Health Purpose Galien Week of innovation What are the next frontiers of patient care offered by MedTech devices and diagnostics in your therapeutic area?
2023 Megan O’Meara Seagen Inc. Senior Vice President, Head of Clinical Development Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Michael Vasconcelles, M.D., PhD ImmunoGen, Inc. Exec VP, Research, Development, and Medical Affairs Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Lusong Lu BeiGene SVP, External Innovation Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Kailash Swarna Accenture Managing Director - Moderator Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Jordan Schecter The Janssen Pharmaceutical Companies of Johnson & Johnson and Legend Biotech USA Inc Vice President for Cellular Therapy Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Eric Richards, MS, MPH Daiichi Sankyo & AstraZeneca Senior Vice President, Head of Global Regulatory Affairs Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Rachel Kobos, MD The Janssen Pharmaceutical Companies of Johnson & Johnson Vice President Oncology Research & Development Galien Week of innovation What are the latest estimations of progress in your respective fields of cancer research, i.e. hematologic and solid tumor cancers? What does the future hold for immunotherapy, precision medicine, cancer vaccines and cancer prevention?
2023 Nafeez Zawahir, MD Razorfish Health Chief Medical Officer - Moderator Galien Week of innovation In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases?
2023 Alejana Gurtman Pfizer Inc. SVP, Vaccine Clinical Research and Development Galien Week of innovation In the aftermath of the Covid-19 pandemic, what is the state of the vaccine business model? Will climate change, urbanization and an aging population require more investments in fighting a growing incidence of infectious diseases?
2023 Jane Parnes Amgen USA Executive Medical Director Galien Week of innovation As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?
2023 Amy Sehnert Bristol Myers Squibb Vice President, Head of Cardiomyopathy and Heart Failure Clinical Development Galien Week of innovation As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?
2023 Amir Kalali CNS Summit, Co-Chair Decentralized Trial Research Alliance Chairman, Chief Curator - Moderator Galien Week of innovation As more complex conditions respond to improvements in our under- standing of the biology behind disease, what can patients expect to see in the form of new treatments in your respective therapeutic areas of expertise?
2023 Michael Rosenblatt, MD Galien Forum Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc. Galien Forum USA Challenges to Individual and Public Health
2023 Sue Desmond-Hellmann, MD, MPH Galien Forum Former Chief Executive Officer of the Bill & Melinda Gates Foundation. Co-Chair of the Galien Forum Galien Forum USA Challenges to Individual and Public Health
2023 John Maraganore, PhD Alnylam Pharmaceuticals Former and Founding CEO Galien Forum USA Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023 Sangeeta N. Bhatia, MD, PhD Massachusetts Institute of Technology John J. and Dorothy Wilson Professor; Electrical Engineering and Computer Science, Institute for Medical Engineering and Science, Massachusetts Institute of Technology Galien Forum USA Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023 Adam Koppel, MD, PhD Bain Capital Life Sciences Partner Galien Forum USA Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023 Mike Nally Flagship Pioneering Chief Executive Officer, Generate Biomedicines; CEO-Partner Galien Forum USA Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023 Daphne Zohar PureTech Health Founder & Chief Executive Officer, Member of the Board of Directors Galien Forum USA Tomorrow’s Innovation Imperative: Conceiving, Creating and Building BioPharma Companies
2023 Jeffrey Shaman, PhD Columbia University Professor and Director of the Climate and Health Program Galien Forum USA Climate Change and Public Health
2023 Gwen W. Collman, PhD, FISEE National Institutes of Health Director, Office of Scientific Coordination, Planning and Evaluation; National Institute of Environmental Health Sciences Galien Forum USA Climate Change and Public Health
2023 Ruxana aghia Akli The Janssen Pharmaceutical Companies of Johnson & Johnson Global Head, Global Public Health R&D Galien Forum USA Climate Change and Public Health
2023 Jessica Fanzo The Columbia Climate School Professor of Climate; Director, Food for Humanity Initiative Galien Forum USA Climate Change and Public Health
2023 Andy Haines London School of Hygiene & Tropical Medicine Professor of Environmental Change and Public Health Galien Forum USA Climate Change and Public Health
2023 Joel S. Marcus Alexandria Real Estate Equities, Inc./Alexandria Venture Investments; Co-Founder, Alexandria Summit; Board Director, Navy SEAL Foundation and National Medal of Honor Museum; Co-Founder, OneFifteen Executive Chairman & Founder Galien Forum USA A National Imperative to Combat Mental Illness and Addiction
2023 Lynne Zydowsky, PhD Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; President & Co-Founder, Alexandria Summit Chief of Science Galien Forum USA A National Imperative to Combat Mental Illness and Addiction
2023 Robin King The Navy Seal Foundation CEO Galien Forum USA A National Imperative to Combat Mental Illness and Addiction
2023 Reesentative Seth Moulton Massachusetts’ Sixth Congressional District; U.S. Marine Corps (Ret.) Member of Congress Galien Forum USA A National Imperative to Combat Mental Illness and Addiction
2023 Reesentative Michael Waltz Florida’s Sixth Congressional District; U.S. Army Green Beret (Ret.); National Guard (Ret.) Member of Congress Galien Forum USA A National Imperative to Combat Mental Illness and Addiction
2023 Michael Rosenblatt, MD Galien Forum Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc. Galien Forum USA Exclusive fireside chat featuring Alex Gorsky, former Chairman& CEO, Johnson & Johnso
2023 Alex Gorsky Johnson & Johnson Former Chairman and CEO Galien Forum USA Exclusive fireside chat featuring Alex Gorsky, former Chairman& CEO, Johnson & Johnso
2023 Bernard Poussot Roche Holding & Cargill Inc. Former Chairman & CEO, Wyeth; Prix Galien Committee Chair (Categories: Medtech, Digital Health, IAE and StartUp) Board Member Galien Forum USA Prix Galien Awards Ceremony - Categories: Best Medical Technology, Best Digital Health Solution, Best Incubator/Accelerator/Equity and Best StartUp
2023 . Mikael Dolsten Pfizer Research and Development Chief Scientific Officer & President Galien Forum USA Obesity Science & Treatment Breakthroughs
2023 Stephen L. Gough Novo Nordisk Global Chief Medical Officer and Senior Vice President of Global Medical Affairs Galien Forum USA Obesity Science & Treatment Breakthroughs
2023 Lee M. Kaplan, MD, PhD Geisel School of Medicine at Dartmouth Professor of Medicine and Chief of the Section on Obesity Medicine Galien Forum USA Obesity Science & Treatment Breakthroughs
2023 Joe Nadglowski Obesity Action Coalition President & CEO Galien Forum USA Obesity Science & Treatment Breakthroughs
2023 Daniel M. Skovronsky, MD, PhD Eli Lilly and Company Executive Vice President, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories Galien Forum USA Obesity Science & Treatment Breakthroughs
2023 Søren Tullin Boehringer Ingelheim Senior Vice President & Global Head of Cardio Metabolic Disease Research Galien Forum USA Obesity Science & Treatment Breakthroughs
2023 James J. Collins Broad Institute of MIT and Harvard Termeer Professor of Medical Engineering & Science Professor Galien Forum USA AI’s Impact on Personal — and Public Health, Now & in the Future
2023 Regina Barzilay MIT School of Engineering Distinguished Professor for AI and Health Galien Forum USA AI’s Impact on Personal — and Public Health, Now & in the Future
2023 Eric Horvitz Microsoft Chief Scientific Officer Galien Forum USA AI’s Impact on Personal — and Public Health, Now & in the Future
2023 Ariel Katz H1 CEO & Co-founder Galien Forum USA AI’s Impact on Personal — and Public Health, Now & in the Future
2023 Steve Quake Chan Zuckerberg Initiative Head of Science Galien Forum USA AI’s Impact on Personal — and Public Health, Now & in the Future
2023 Lieven Van der Veken McKinsey & Company Senior Partner Galien Forum USA AI’s Impact on Personal — and Public Health, Now & in the Future
2023 Petra Jantzer, PhD Accenture Senior Managing Director, Global Life Sciences Lead Galien Forum USA Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023 Michael Rosenblatt, MD Galien Forum Prix Galien Committee Chair (Categories: Pharma, Biotech, Rare/Orphan) and Co-Chair of the Galien Forum; Former Dean of Tufts University School of Medicine, Former Chief Medical Officer of Merck & Co. Inc. Galien Forum USA Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023 Albert Bourla Pfizer Chairman & CEO Galien Forum USA Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023 Michael J. Dowling Northwell Health President & CEO Galien Forum USA Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023 David R. Epstein Seagen CEO Galien Forum USA Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
2023 David A. Ricks Eli Lilly and Company Chair & CEO Galien Forum USA Science Meets Society: Balancing Innovation, Equity and Public Health in a Post-COVID World
ColImage

TOP SCIENTISTS & KOL

Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.

SEE WHO HAS SPOKEN